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Abstract 
Successful management of diabetes requires frequent appointments with healthcare 
professionals, many of which take place in hospital outpatient departments.  Trips to hospital 
can be both burdensome and expensive for patients.  Several studies have investigated the 
feasibility and effectiveness of videoconferencing for remote provision of diabetes care, but 
most have focused on behavioural therapy interventions such as diabetes education, self-
management training, and nutrition consultations which are commonly provided by non-
physician health professionals. A few clinical trials have reported the clinical outcome of 
videoconferencing for diabetes care, but no study has been reported on the reliability of video 
consultation for diabetes specialised care. 
The aim of this research was to evaluate the reliability of videoconferencing for clinical 
management of diabetes. Three preliminary studies were conducted to inform the design of a 
randomised controlled trial.  In the first study, the process of care, delivered by 
endocrinologists during conventional consultations in a diabetes outpatient clinic was 
analysed. This study showed that physical examination was not performed in 34% of in-
person consultations. The endocrinologists reported that in 86% of the cases, it would be 
possible to safely provide the same consultation remotely via videoconferencing if the patient 
was accompanied by a general practitioner at the remote site. This could save the patients 
cost and inconvenience of long trips. 
In the second study, the process of consultations provided remotely by endocrinologists via 
videoconference was analysed. This study was conducted in the tele-endocrinology clinic of a 
tertiary teaching hospital in Brisbane, which provides specialty consultations remotely to the 
patients living up to 1800 km away. Fifty six video consultations during a 5-month period 
were analysed. A nurse accompanied the patients at the remote site in 66% of the 
consultations, and in 18% of these cases, the endocrinologists requested the nurse to perform 
a physical examination. The most frequent recommendations were requesting lab tests (75%), 
adjustment of insulin dose (39%) and referring to an allied health professional (13%). Of 
these 56 consultations, the endocrinologists requested an in-person visit for three patients. 
In the third study in the same tele-endocrinology clinic, a questionnaire for assessing the level 
of patient satisfaction with video consultation was developed.  It comprised 15 multiple 
choice items exploring four dimensions: equipment/technical issues, communication and 
rapport, clinical assessment, and program evaluation. This questionnaire was then used to 
assess the satisfaction of the patients living in rural areas of Queensland who had been 
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remotely consulted by two endocrinologists via videoconferencing. In Autumn 2013 the 
questionnaire was sent by mail to 62 patients and 39% were completed and returned. The 
'communications and rapport' dimension received the highest satisfaction rate and the 'clinical 
assessment' the lowest. The item with highest satisfaction rate was 'video quality' and the 
least satisfaction rate was reported for 'physical contact'. 
Based on the findings of the three preliminary studies, a pilot randomised controlled trial was 
designed to evaluate the reliability of videoconferencing for remote consultation of people 
with diabetes who needed to see an endocrinologist in an outpatient clinic. This trial was 
conducted in the outpatient diabetes clinic of a tertiary teaching hospital in Brisbane. 75 
participants were recruited from October 2012 to July 2013. The participants were randomly 
allocated into a telemedicine group or reference group. Each participant in the telemedicine 
group received two consultations: one in-person consultation and one video consultation. In 
the reference group the participants had two in-person (face-to-face) consultations. The 
paired consultations for each participant were provided by two different endocrinologists. To 
evaluate the reliability of the video consultation, the level of agreement between 
endocrinologists in the telemedicine group was calculated by comparing their 
recommendations on medication changes. In order to be able to assess the impact of 
videoconferencing on the level of agreement between endocrinologists, similar measures 
were also calculated in the reference group where two endocrinologists consulted the 
participants in-person. The findings of this study showed that the level of agreement between 
two endocrinologists on changing anti-diabetes drugs was 64% in telemedicine group and 
78% in the reference group. Although the level of agreement was lower when one of the 
consultations was via videoconference, the difference was neither statistically, nor clinically 
significant. The level of agreement on changing cardiovascular drugs was 78% in the 
telemedicine group and 76% in the reference group, again not significantly different. This 
first rigorous trial of the reliability of videoconferencing for diabetes remote consultation 
produced evidence that the technique is acceptable for the patients who need specialist 
consultation with an endocrinologist.  
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1. INTRODUCTION
1.1. Diabetes Mellitus 
Diabetes Mellitus is a chronic disease which affects more than 220 million people worldwide. 
It is a life-long health condition that requires self-management and ongoing health care. High 
cost of the management of diabetes and its complications, along with the increasing 
prevalence of this disease have made it a challenge for the health care system in many 
countries including Australia.  
Patients with diabetes are at increased risk of various life threatening conditions. It is well-
documented that intensive glycaemic control reduces the risk of development of diabetes 
related complications.1, 2 However, a  large proportion of people with Type 2 diabetes 
(T2DM) do not receive basic minimum standard care that is recommended by international 
guidelines.3 An alarmingly large proportion of patients with poor glycaemic control do not 
receive intensified treatment for hyperglycaemia for a long period of time 4, and continue to 
remain with poor glycaemic control even after the initiation of intensified treatment.5, 6 
Improving access to timely and quality care is the fundamental requirement for effective 
management of this chronic disease.   
1.2. Access to specialist expertise 
There is inequality in access to specialty care between the residents of rural areas (urban 
centre population between 10,000 – 100,000), and metropolitan areas (urban centre 
population over 100,000).7 Many people living in rural and remote areas do not have the 
same access to health care compared with their metropolitan counterparts mainly because of 
the tendency of care facilities and providers, more specifically the specialists, to be 
centralised in urban areas. People with diabetes who live in rural areas are less likely to have 
access to adequate diabetes care.8  
Several strategies have been put in place to improve access to specialty care for the residents 
of underserved areas. In many cases, the governments provide financial support for travel to a 
nearby city where the needed specialist expertise is available for the patients. This, however, 
does not often compensate the time off work of the patient (and the carer if needed to escort 
the patient). Nevertheless, the stress of the journey cannot be compensated easily. Another 
strategy is establishing outreach clinics by the governments to bring the most needed 
specialists to the underserved areas on a pre-scheduled program. Although this approach is 
helpful for managing people with chronic diseases, it usually ends up with long waiting lists 
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for the patients and thus lack of timeliness in access to care. It is also important to know that 
the concept of accessibility to health care has changed over the past decade and expands 
beyond just geographic distance.9 Social and cultural barriers limit access to appropriate care 
for many people around the world, more specifically for the diseases which are associated 
with stigma.10-12 Telemedicine has been recognised as an alternative to patient travel when 
specialist care is not available locally.  
1.3. The role of telemedicine 
Telemedicine, which is defined as the provision of medical opinion, evaluation or 
management services at a distance using information and communication technologies, holds 
the promise of improving access to specialist care by bridging the geographical gap between 
health care providers and consumers and lowering the costs.13 Telemedicine is generally 
delivered in two main formats: Store-and-forward (asynchronous) and real time 
(synchronous). In store-and-forward telemedicine, the health care providers and consumers 
do not necessarily interact with each other in real time. The patients' information is recorded, 
stored, and sent to a health care professional and he/she will attend to it in a convenient time. 
Typical examples of this format of telemedicine are teleradiology and teledermatology in 
which the digital images along with some information about the patient is sent electronically 
to a specialist and the specialist provides a report or comments on the diagnosis or 
management of the patient at a later time. 
In real-time (synchronous) telemedicine, two or more parties interact with each other in the 
real time. This format of telemedicine has been practiced traditionally for decades using 
telephone calls. Videoconferencing is a more advanced format of real time telemedicine that 
has the advantage of communicating non-verbal clues between the parties. Although the use 
of videoconferencing was initially limited due to high cost of equipment and connectivity 
solutions, recent advancements in information and communications technology has made 
videoconferencing more accessible to the general public and patients alike. 
However telemedicine has its own limitation that should be considered, most notably 
inability of the health care provider to perform a physical examination on patient remotely. 
Telemedicine services have been successfully introduced in psychiatry14, dermatology15 and 
radiology16, but application of telemedicine for management of chronic disease is still 
controversial.17 Although a variety of telemedicine applications have been used for diabetes 
care18-20, no published report was found on the reliability of videoconferencing as a medium 
of delivery of specialised care for people with diabetes. Realising the increasing popularity of 
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video consultation, the research project designed for this thesis used videoconferencing as the 
medium of health care delivery. 
1.4. Aims and scopes 
The aim of this research was to investigate the reliability of remote consultation via 
videoconferencing for people with diabetes. As it is possible that a specialty consultation 
provided via videoconference yields an inferior outcome to a face-to-face consultation, it is 
important to know how inferior, if at all, would be the outcome of video consultations 
compared to face-to-face consultations, and what clinical implications such a potential 
difference would have. 
1.5. Overview of the study 
The body of this thesis is divided into three sections: 
• Section 1: Review of the Literature
• Section 2: Preliminary studies
• Section 3: The Main Research Study
Section 1 (Chapters 2-5) provides an overview of the literature on telemedicine and clinical 
applications of using videoconferencing for clinical purposes. Chapter 2 explores research 
output in the general field of ICT in healthcare and highlights the lack of clarity in the 
terminology of this emerging field of study through a bibliometric analysis of the literature. 
Chapter 3 addresses one common insufficiency in the development of a search strategy for 
using Medical Subject Headings (MeSH) when searching PubMed for randomised controlled 
trials. Chapter 4 describes a review of the published papers on using videoconferencing for 
clinical purposes. Using the results of this literature review, Chapter 5 describes the technical 
characteristics, including the equipment and networking solutions, of the papers that have 
studied videoconferencing interventions in health care. 
Section 2 (Chapters 6-7) describes three preliminary studies that were carried out to inform 
the design of the main research study. Chapter 6 explains the study on the process analysis of 
conventional (in-person) consultations for people with diabetes. Through a similar approach, 
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Chapter 7 presents the study on the process analysis of diabetes remote consultation in a tele-
endocrinology clinic. Chapter 8 describes a study on the patient satisfaction with video 
consultation. In this study a questionnaire was developed and used for assessing patient 
satisfaction with videoconferencing in a Tele-endocrinology clinic. 
Section 3 (Chapters 9-11) describes the main study of this thesis. Chapter 9 explains the 
methodology of a novel research design for assessing the reliability of videoconferencing for 
remote consultation of diabetes. Chapter 10 reports the conduct of this study and the results. 
Finally, Chapter 11 summarises the aims, scopes, and findings of the whole research program 
and discusses the practical implications of the results 
4 
Section 1: Review of the Literature 
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2. TELEMEDICINE, TELEHEALTH, OR EHEALTH? A BIBLIOMETRIC
ANALYSIS
2.1. Paper Information 
Telemedicine, which is traditionally defined as the provision of medical services at a 
distance, emerged as a new concept more than a century ago. At that time telecommunication 
systems were used for communicating clinical information. However, over time, the 
applications of telemedicine expanded to other health related purposes such as education and 
administration. With emergence of new technologies and employing them in health and 
clinical services, other terms such as eHealth and mHealth were also introduced to the 
literature, adding more ambiguity to the terminology of this field of science. 
Having a clear understanding of the main key terms in each scientific field of study is 
essential to the successful exploration of the specialised literature. This study aimed to 
discover how consistent the main three key terms of this field (i.e. telemedicine, telehealth, 
and ehealth) have been used in the literature and identify any difference in their usage 
between the countries around the world. This exploratory study informed the development 
and optimisation of search strategy in the field of telemedicine for various purposes including 
identifying the research gap.  
The following paper has been published in the Journal of Telemedicine and Telecare (2012), 
Volume 18, Issue 8, pages 460-464. The candidate, Farhad Fatehi, was primarily responsible 
for conducting the research and writing the manuscript. The paper's co-author, Richard 
Wootton, contributed to this paper in various aspects as listed in the preliminary pages of this 
thesis.  
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Q Telemedicine, telehealth or e-health?
A bibliometric analysis of the trends in the
use of these terms
Farhad Fatehi*† and Richard Wootton‡§
*Centre for Online Health, University of Queensland, Brisbane, Australia; †School of Advanced Medical Technologies, Tehran University of
Medical Sciences, Tehran, Iran; ‡Norwegian Centre for Integrated Care and Telemedicine, University Hospital of North Norway, Tromsø,
Norway; §Faculty of Health Sciences, University of Tromsø, Norway
Summary
The terms ‘telemedicine’, ‘telehealth’ and ‘e-health’ are often used interchangeably. We examined the occurrence of these
terms in the Scopus database. A total of 11,644 documents contained one of the three terms in the title or abstract.
Telemedicine was the most common term, with 8028 documents referring to it, followed by e-health (n ¼ 2573) and then
telehealth (n ¼ 1679). Telemedicine was referred to in documents from 126 countries; the terms telehealth and e-health
were found in publications from 55 and 99 countries, respectively. Documents with telemedicine in their title or abstract
first appeared in 1972, and continued to appear at a low rate until 1994 when they started to increase rapidly; telehealth
showed a similar pattern, but with the growth beginning about five years later. Although articles containing the term
e-health appeared later than the other two terms, the rate of increase was higher. Articles ( journal papers) were the most
common type for the three key terms, followed by conference papers and review articles. Publication rates for telemedicine
or telehealth or e-health were compared with two other relatively new fields of study: Minimally Invasive Surgery (MIS) and
Highly Active Antiretroviral Therapy (HAART). Publications concerning HAART seem to have reached a peak and are now
declining, but those with the three key terms and those concerning MIS are both growing. The variation in the level of
adoption for the three terms suggests ambiguity in their definition and a lack of clarity in the concepts they refer to.
Introduction
Telemedicine has been researched for more than a century.
However, the terminology in this field of study suffers from
a lack of clarity and an absence of agreement about the
definitions of the concepts. The term ‘telemedicine’ was
originally used to denote the provision of medical services
across distance (this is the literal meaning of the word). As
the application of telemedicine widened, the term
‘telehealth’ was introduced to reflect a broader scope of
health-related functions such as education and
administration. More recently, terms like e-health, m-health
and connected health have emerged. The term e-health, for
example, was coined to cover a broad range of data
processing and computer networking applications
(including use of the Internet) in health care.
Chronological observation of the usage of these terms in
the literature suggests that the newer themes of telehealth
and e-health can be considered as an expansion of the
original term telemedicine. However, the terms
‘telemedicine’, ‘telehealth’ and ‘e-health’ are often used
interchangeably by both health care providers and
consumers.1–3 The aim of the present study was to discover
how consistently the key terms in this field have been used
in the literature, to determine their trends over the past few
years and to identify any differences in their usage between
different countries.
Methods
The Scopus electronic database was searched to retrieve all
publications referring to the terms ‘telemedicine’,
‘telehealth’ or ‘e-health’. The Scopus database covers a wider
range of sources than PubMed and Web of Science, and
offers advanced search facilities which allow the searching
of various fields, including Title and Abstract.4 It also
provides an analysis of results feature.
The search was conducted in September 2012 via the
Scopus website. The terms telemedicine, telehealth and
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e-health were used to search the title, abstract and title/
abstract of articles indexed by Scopus. Since these terms
may be written with or without a hyphen or space between
the prefix and the stem (e.g. ‘e-health’, ‘e health’ or
‘ehealth’), three spelling variants were used for searching
each key term using the OR operator. The following queries
were used in the Advanced Search page on the Scopus
website to retrieve articles for ‘telemedicine’:
(1) TITLE(ftelemedicineg OR ftele medicineg OR
ftele-medicineg)
(2) ABS(ftelemedicineg OR ftele medicineg OR
ftele-medicineg)
(3) (TITLE(ftelemedicineg OR ftele medicineg OR
ftele-medicineg)) OR (ABS(ftelemedicineg OR
ftele medicineg OR ftele-medicineg))
Similar queries were used for telehealth and e-health. No
limitation was applied to the date of publication, the
journal category in the database or the language of the
documents.
Documents published in 2012 were excluded to avoid
incomplete statistics. The built-in analysis capability of
Scopus was used to analyse the distribution of papers over
time, by document type and by country. Unlike PubMed,
Scopus indexes the affiliations (including the country) of all
authors, i.e. a document may have more than one country
associated with it if the authors are from different countries.
To compare the rate of publication in the domain of
interest with other scholarly domains, the total number of
documents concerning the three terms ‘telemedicine’,
‘telehealth’ and ‘e-health’ (referred to collectively as ‘ICT
health’) was examined. Two other relatively new fields of
study were selected for comparison: Minimally Invasive
Surgery (MIS) and Highly Active Antiretroviral Therapy
(HAART). These techniques are also technology intensive
and were developed in the 1980s and 1990s, i.e. at
approximately the same time as telemedicine began to be
used widely.5 To compare these three domains, the basic
document search in Scopus was used to search the title,
abstract or keywords of the documents (this search
procedure yields a slightly higher number of results
compared to the exact phrase search described above).
Results
A total of 11,644 documents contained the term
telemedicine or telehealth or e-health in the title or
abstract. Telemedicine was the most common term, with
8028 documents referring to it, followed by e-health
(n ¼ 2573) and then telehealth (n ¼ 1679). The number of
documents referring to each term as well as their
combinations in title, abstract and title/abstract are shown
in Table 1. The majority of these articles (93%) were in
English, see Table 2.
Year
Documents with telemedicine in their title or abstract
appeared in 1972 with four instances, and continued at
about the same rate until 1994 when they started to increase
rapidly. There was a brief decline in the number of
telemedicine documents starting in the year 2000.
Documents containing the term telehealth appeared in
1978 and continued with less than four documents per year
until 1996 when a steady growth started. Although articles
containing the term e-health appeared later than the other
two terms, the rate of increase was higher. The number of
e-health publications showed a dip starting in 2000, but it
was less pronounced than for telemedicine, see Figure 1.
Table 1 Number of documents with telemedicine, telehealth, e-health
and their combinations in title or abstract (see text) for the period
1972–2011
Title Abstract Title or Abstract
telemedicine 4697 6167 8028
telehealth 1057 1270 1679
e-health 1438 1988 2573
telemedicine OR telehealth 5704 7211 9401
telemedicine OR e-health 6063 7930 10,313
telehealth OR e-health 2487 3198 4182
telemedicine OR telehealth
OR e-health
7064 8937 11,644
Table 2 Language of the articles retrieved using the three search terms
telemedicine, telehealth and e-health in the title or abstract
No (%)
English 10,789 (93)
German 263 (2)
French 124 (1)
Spanish 91 (0.8)
Italian 78 (0.7)
Japanese 53 (0.5)
Chinese 48 (0.4)
Russian 39 (0.3)
Portuguese 25 (0.2)
Other 134 (1)
Total 11,644 (100)
Figure 1 Number of documents per year
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Country
Telemedicine was referred to in documents from 126
countries (i.e. about half of the countries in the world). The
terms telehealth and e-health were found in publications
from 55 and 99 countries, respectively. The top ten
countries for documents concerning telemedicine are
shown in Figure 2. The occurrence of the other two terms is
also shown.
The term telehealth was more popular among countries
in which English was the official language (e.g. the UK,
USA, Canada and Australia). Canada had the highest
proportion of documents with the term telehealth (30%)
and the lowest for telemedicine (37%).
The trend of publications was similar among the top five
countries with the highest number of publications in the
past 20 years. The dip in 2002 in the number of documents
with the three terms occurred in all countries except
Canada (Figure 3).
Document type
Articles ( journal papers) were the most common type for
the three key terms, followed by conference papers and
review articles. However, the proportion of conference
papers for e-health (38%) was higher than for telemedicine
(23%) or telehealth (16%), see Table 3. The number of
conference papers referring to each key term is shown in
Figure 4. E-health and telemedicine were substantially more
popular than telehealth in conference papers (Figure 4).
Other scholarly domains
In 2011 there were 1960 articles with the terms
telemedicine, telehealth or e-health appearing in their title
or abstract, or being assigned as the keyword (either by the
authors or by Scopus). In the same year there were 2507
articles concerning HAART and 3854 concerning MIS.
Publications concerning HAART seem to have reached a
peak and are now declining, but ICT health and MIS are
both growing (Figure 5).
The trends of publications for MIS and HAART were
similar among the countries with the highest number of
documents. Similar to ICT health, the trends of MIS
publications showed a slight reduction in these countries in
2000/2001, with more effect in countries with fewer
publications.
Discussion
The number of publications on telemedicine, telehealth
and e-health shows an overall growth in the past two
Figure 3 Total number of publications (log scale) referring to
telemedicine, telehealth or e–health since 1990
Table 3 Numbers of different document types (values in parentheses
are percentages) referring to telemedicine, telehealth and e-health in
the title or abstract for the period 1972 to 2011
Telemedicine Telehealth E-health
Article 4636 (58) 1074 (64) 1062 (42)
Conference paper 1833 (23) 284 (17) 1001 (38)
Review 895 (11) 202 (12) 227 (9)
Editorial 161 (2) 21 (1) 76 (3)
Other 503 (6) 98 (6) 204 (8)
Total 8027 (100) 1679 (100) 2570 (100)
Figure 4 Number of conference papers per year
Figure 2 Number of documents for each key term per country
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decades. With some fluctuations for all three terms, the
number of documents containing ‘telemedicine’ and
‘e-health’ have been increasing faster than that of
‘telehealth’. Based on the trends for the last ten years there
will be more documents referring to ‘e-health’ than
‘telemedicine’ by 2022 (Figure 6). If the trend for the last
five years is considered instead, it will happen by 2016.
The rapid growth in popularity of e-health in conferences
during the past six years suggests that similar growth will
happen in the number of e-health journal papers in future.
The majority of publications (85%) were from high
income countries (according to the World Bank’s
classification6), whereas less than 1% (n ¼ 42) of all the
documents were from low income countries (Figure 7).
While ICT health has been claimed to improve access to
health care and reduce the costs,7 low-middle income
countries in which these two issues are more challenging,
have had less contribution in scientific production in this
field.
There was a pronounced fall in the number of
publications containing the term telemedicine starting in
the year 2000. We do not know the reason for this. A search
for documents containing the terms telemedicine,
telehealth and e-health in other databases shows the same
phenomenon: a growth in the number of articles beginning
in the early 1990s, with a dip in 2000. Figure 8 shows the
results for the Scopus database, for PubMed and for Web of
Science, i.e. the fall is not specific to the Scopus database,
but occurs in all of them. This suggests a common factor,
such as a sudden, temporary reduction in the number of
papers being published, or a sudden reduction in the
number of journals being indexed by the databases. Neither
seems a particularly likely explanation.
Figure 5 Number of publications for ICT health, MIS and HAART
per year
Figure 6 Linear forecast of the number of publications indexed in
Scopus based on the previous ten years
Figure 7 Publication by economy group of countries: articles with the
terms telemedicine, telehealth or e-health. High income countries
accounted for 85% of the publications
Figure 8 Annual number of documents containing the term
telemedicine OR telehealth OR e–health (without their spelling
variants) in three databases. The values for each curve have been
normalized to the number of documents found in 2000
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Limitations
The present study had certain limitations. A proportion of
incomplete entries, duplicate records or erroneous data has
to be expected in any electronic database. Such errors have
been reported in electronic literature databases, including
Scopus.4 Therefore in the present study, the search results
might have included some non-relevant records. Although
the search query was developed according to the
recommendations of Scopus Help for finding an exact
phrase, a few of the publications retrieved were found to be
non-relevant (e.g. a paper with an abstract which reads
‘. . . all members of the A and E health care team’ published
in 1993). Where identified, corrections were made by hand
to eliminate these false positive results. In addition, the
Scopus statistics output was not complete for country
analysis, which might have introduced an underestimation
for some countries with variations for the three key terms.
The missing country data was seen in documents referring
to telemedicine (30%), telehealth (31%) and e-health (7%),
but may have been evenly distributed among countries.
Conclusion
The variation in the level of adoption for the three terms
suggests ambiguity in their definition and a lack of clarity in
the concepts they refer to. Telemedicine is a more popular
term than telehealth or e-health, based on the number of
publications in the Scopus database. The term e-health is
more popular than telehealth in non-English speaking
countries. The increasing number of publications suggests
that this field of study is still growing. It appears that the
term e-health will be more popular than telemedicine or
telehealth within the next ten years.
Acknowledgement: We thank Mr Saeed Mohammadi,
School of Business, Queensland University of Technology,
for helpful discussions.
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3. USING MESH TERMS FOR SEARCHING PUBMED ON 
TELEMEDICINE FOR DIABETES 
3.1.  Paper information 
Development of electronic bibliographic databases has provided researchers with 
unprecedented capabilities in searching for and retrieving scientific information. However, 
the huge volume of ever increasing digital information and the complexity of search 
algorithms deployed in many electronic databases have made the task of conducting an 
efficient and successful electronic search a challenge for the users. 
The aim of this paper was to highlight the importance of correct development of a search 
strategy for searching PubMed, and the consequences of using a suboptimal search query in a 
case of systematic review on telemedicine for diabetes, which is the main topic of this thesis. 
The following paper has been published in the Journal of Telemedicine and Telecare (2013), 
Volume 19, Issue 3, pages 175-176. The candidate, Farhad Fatehi, was primarily responsible 
for conducting the research and writing the manuscript. The paper's co-authors, Dominique 
Bird and Leonard C Gray, contributed to this paper in various aspects as listed in the 
preliminary pages of this thesis.  
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TAILPIECE Correspondence
PubMed searching using MeSH terms to
identify randomized controlled trials on
telemedicine for diabetes
The identification of all potentially relevant papers is crucial
to the systematic review process. This requires the literature
search to be as sensitive as possible, rather than specific.
However, developing an optimum search strategy for
retrieving relevant information from electronic databases is
a challenge.1 The rapid growth in the quantity and
complexity of the scientific literature has necessitated
sophisticated methods to organise and index data, and
subsequently to search it. Electronic database users rely on
the use of keywords and subject headings to search, refine
the results and retrieve the information.
The US National Library of Medicine (NLM) developed
the Medical Subject Heading (MeSH) indexing system for
cataloguing and categorizing the biomedical scientific
documents stored in MEDLINE. Although MeSH has been
shown to facilitate information retrieval from MEDLINE via
the PubMed interface2, there are certain limitations
associated with using MeSH for searching the literature.
These limitations include insufficiency and inconsistency in
tagging the papers by NLM indexers, and modification of
index terms over time. These limitations, and various types
of inaccuracy in the bibliographic indexing of documents,
make searching electronic databases, including MEDLINE/
PubMed, an imprecise task especially for systematic reviews.
PubMed users should therefore use MeSH terms with
caution for the purpose of a comprehensive literature
review. A search query based solely on MeSH terms will fail
to retrieve papers that NLM indexers have indexed
insufficiently. A recent cross sectional study showed that
572 randomised controlled studies entered into MEDLINE
in 2005 were not tagged with the appropriate MeSH term.3
Although the NLM immensely aided the identification of
randomized controlled trials (RCTs) by introducing the
“Randomized Controlled Trial” [Publication Type] in 1991,
its similarity to “Randomized Controlled Trials as Topic”
[Mesh] is still confusing for users (see below).4
We read with interest the review of telemedicine
interventions in diabetes care by Siriwardena et al.5 but
noticed that a highly cited relevant RCT6 was missing from
the results. This led us to examine the paper’s methods to
understand whether the search strategy failed to retrieve
this study, or whether it had been intentionally excluded
from the review. We conducted a PubMed search using the
terms “Diabetes Mellitus”[Mesh] AND “Telemedicine”
[Mesh] AND “Randomized Controlled Trial”[Publication
Type]. This yielded 81 papers meeting the inclusion criteria
(with the cutoff date limited to June 2011 as indicated in
the original paper). This is nearly twice the number of
papers identified as potentially relevant in Siriwardena
et al.’s review (47 papers). A substantial number of missing
papers may affect the comprehensiveness of the review,
both in terms of the number of studies included and the
summarising of the results.
“Randomized Controlled Trials” [MeSH] as indicated in
the paper’s search strategy cannot identify all randomised
controlled trials (RCT) because this MeSH term is used for
indexing papers whose topic is an RCT. Instead, PubMed
users must use “Randomized Controlled Trial” [Publication
Type] for identifying studies that report the conduct or
results of randomised controlled trials.
Our own PubMed search for RCTs on telemedicine
for diabetes found several additional relevant papers
that appeared to be telemedicine related6–10, diabetes
related11–13 or randomised controlled trials.14–17 These
papers had not been tagged properly with the relevant
MeSH terms. Furthermore, as Telemedicine was introduced
in the MeSH database in 1993, a PubMed search for related
papers using “Telemedicine” [MeSH] will not retrieve
relevant studies which were indexed prior to that year
unless they were updated afterwards.
Including all the relevant papers returned by a better
search could improve Siriwardena et al.’s review. For
example, it could add another group of papers reporting the
results of RCTs using web-based or online interventions
(without any telephone or video call)18–21 to the currently
summarised three groups (Videoconference, Mobile phone
and Telephone calls). Nevertheless, it would probably not
change the overall conclusion of the review, that
“telemedicine is a promising alternative to conventional
therapy” and that “behavioural therapy enhanced by
telemonitoring appears to be the most suitable mode of
intervention”.
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4. CLINICAL APPLICATIONS OF VIDEOCONFERENCING: A SCOPING 
REVIEW  
4.1.  Paper information 
Telemedicine solutions are generally classified into two main categories: synchronous (real-
time) and asynchronous (store-and-forward). Videoconferencing (VC) is a synchronous mode 
of telemedicine that allows two or more parties to interact with each other by simultaneous 
exchange of video and audio. Although VC was initially possible by using relatively high-
cost dedicated equipment and telecommunication infrastructure, recent advancements in ICT 
have made it more accessible to the general public by various software solutions running on 
desktop computer systems or more recently via portable devices such as notebooks, tablets, 
or smart phones. 
Videoconferencing has been the subject of increasing number of peer-reviewed publications 
over the past decade, but no published report was found on the clinical applications of VC in 
general. Most of the systematic reviews limit their scopes to randomised controlled trials and 
a very specific application of videoconferencing, ending up with a relatively small number of 
papers. None of those review studies can give a general picture of the use of 
videoconferencing for clinical purposes. The aim of this review was to summarise the 
original studies that have scientifically evaluated various aspects of implementing 
videoconference technology for clinical purposes.  
The following paper has been published in the Journal of Telemedicine and Telecare (2014), 
Volume 20, Issue 7, pages 377–383. The candidate, Farhad Fatehi, was primarily responsible 
for design of the study, conducting the research and writing the manuscript. The paper's co-
authors, Nigel R Armfield, Mila Dimitrijevic and Leonard C Gray contributed to this paper in 
various aspects as listed in the preliminary pages of this thesis. 
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Clinical applications of videoconferencing: a
scoping review of the literature for the
period 2002–2012
Farhad Fatehi1,2, Nigel R Armfield1,3, Mila Dimitrijevic1 and
Leonard C Gray1,4
Summary
We conducted a scoping review of the literature on the clinical applications of videoconferencing. Electronic searches were
performed using the PubMed, Embase and CINHAL databases to retrieve papers published from 2002 to 2012 that described
clinical applications of videoconferencing. The initial search yielded 4923 records and after removing the duplicates and screen-
ing at title/abstract level, 505 articles met the inclusion criteria and were reviewed at full-text level. The countries with the
highest number of papers were the US, Australia and Canada. Most studies were non-randomised controlled trials. The
discipline with highest number of published studies (39%) was mental health, followed by surgery (7%) and general medicine
(6%). The type of care delivered via video comprised acute, sub-acute and chronic care, but in 44% of the papers, the inter-
vention was used for a combination of these purposes. Videoconferencing was used for all age groups but more frequently for
adults (20%). Most of the papers (91%) reported using videoconferencing for several clinical purposes including management,
diagnosis, counselling and monitoring. The review showed that videoconferencing has been used in a wide range of disciplines
and settings for different clinical purposes. The practical value of published papers would be improved by following standard
guidelines for reporting research projects and clinical trials.
Accepted: 9 August 2014
Introduction
Videoconferencing, which is the primary modality for syn-
chronous telemedicine, has been used for real-time deliv-
ery of a range of clinical and health care services at a
distance. Advances in information and communication
technologies (ICT) have made videoconferencing more
affordable for health care providers and the public. It is
now possible to carry out video-based remote consult-
ations using free software applications on a desktop com-
puter or on a mobile phone.1
Bibliometric studies have shown a substantial increase
in the number of published papers on telemedicine during
the past five decades,2–6 but it is not clear what proportion
of these papers have used videoconferencing. Therefore
the overall picture of the usage of videoconferencing for
clinical purposes remains unclear. Most of the systematic
reviews have limited their scope to randomised controlled
trials (RCT) in a specific medical discipline, resulting in a
relatively small number of papers being considered. This
means that a considerable proportion of papers, which
have been published in peer-reviewed journals, have
been excluded from review studies.
Much experience has been gained over the past decade
on different aspects of conducting systematic reviews, such
as literature searching, critical appraisal of eligible papers
and methods for summarising the results, including meta-
analysis of RCTs. However, systematic reviews of non-
RCT studies are rather limited.7 A scoping review can
be used in a complex and broad field of study in which
a meta-analysis of the findings is not feasible. A scoping
review can map the related literature and examine the
extent, range and nature of research activities. Unlike sys-
tematic reviews, scoping reviews do not attempt to syn-
thesize evidence by aggregating findings from studies, but
instead collate and summarise the key characteristics of
the literature.
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We conducted a scoping review of the literature on the
clinical applications of videoconferencing. The aim of the
study was to map the global research output and to iden-
tify the breadth of literature related to this mode of
telemedicine.
Methods
A modified version of Arksey and O’Malley’s framework8
was adopted. This framework, which was one of the first
attempts to clarify the methods for scoping reviews,
suggests five stages for conducting a scoping study:
1. identifying the research question;
2. identifying relevant studies;
3. selecting the studies;
4. charting the data;
5. collating, summarising and reporting the results.
It also includes an optional sixth stage, which is a consult-
ation exercise.8,9 We developed a search strategy, screened
the search results according to eligibility criteria, designed
a data extraction form and summarised the papers that
reported on telemedicine services based on videoconferen-
cing in clinical settings.
Search strategy and data sources
Online literature searches were performed using the
PubMed, Embase and CINAHL databases. The search
strategy for PubMed is shown in Table 1. A combination
of relevant MeSH terms and keywords were used to
ensure that the search was highly sensitive.10 Similar
strategies were developed for searching Embase and
CINAHL according to their user interfaces. We reviewed
the articles published between January 2002 and
December 2012. Because computers and related products
become obsolete relatively quickly, articles published ear-
lier than 2002 were not included. Reference management
software (EndNote version X6) was used to record the
identified articles and check for duplicates. We considered
all interventions that used videoconferencing for clinical
purposes, regardless of the type of devices and communi-
cation technology used. There was no limitation on the
participants of the studies, so health care professionals,
patients and patients’ carers or family members could be
participants in the studies.
Eligibility criteria, screening and selection of studies
The focus of the review was on the use of videoconferen-
cing for patient care, and so we included original research
papers in which videoconferencing was the main or one of
the main topics of research and in which videoconferen-
cing had been used for clinical purposes, not primarily for
administration or education. Review papers, conference
proceedings, case studies, letters and comments were
excluded. We also excluded papers that solely explored
technical or economic aspects of videoconferencing.
The articles retrieved from the literature search were
initially screened at title and abstract level by two
reviewers. Publications lacking an abstract in the English
language were excluded. Disagreements were resolved by
consensus, or by consulting a third reviewer. The full text
of potentially relevant studies was obtained for final eligi-
bility assessment. If the information provided by the title/
abstract of a paper was not sufficient for deciding on
inclusion or exclusion, the article was regarded as poten-
tially relevant and the full text retrieved. In the case of
duplicate publications and companion papers of a pri-
mary study, the paper with most comprehensive informa-
tion was included.
Data extraction
Information was extracted from the selected papers using
a data extraction form that was developed for the study.
Two reviewers independently checked the full-text of ten
Table 1. Search strategy for PubMed.
Search
step Query
1 video
2 videoconferencing [Mesh]
3 videoconferenc*
4 video conferenc*
5 videoconsult*
6 video consult*
7 videoteleconferenc*
8 video-teleconferenc*
9 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8
10 telemedicine [Mesh]
11 telemedicin*
12 tele-medicine
13 telemonitor*
14 remote monitor*
15 telehealth
16 tele-health
17 ehealth
18 e-health
19 telecare
20 telecare
21 tele-care
22 remote consultation [Mesh]
23 remote consult*
24 teleconsult*
25 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17
OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24
26 9 AND 25
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included papers and extracted the information using this
form. The results were then compared with each other and
disagreements were resolved by discussion, after which the
form was revised where necessary. Then the information
from the rest of the papers was extracted by one reviewer.
Because of the heterogeneity of the studies, a meta-
analysis of the results was not feasible. Instead a qualita-
tive approach was adopted. The findings are reported
below in a narrative format.
Information was extracted regarding year of publica-
tion, country where the telemedicine project was con-
ducted, medical discipline, type of care, age group, type
of patients (new or review), type of trial (efficacy study
conducted in a controlled way for the purposes of
research, or effectiveness study conducted in routine clin-
ical care in ‘real-world’ conditions), demographics of
health care providers and patients, host of the video-
conferencing session and the setting of videoconferencing.
The age group (paediatric, adult, geriatric) was that
defined in the papers. The purpose (primary, as well as
secondary purpose if applicable) of videoconferencing
was also extracted and categorised. The level of evidence
of the papers was assessed based on the design of the
study.11 No attempt was made to assess the meth-
odological and reporting quality of the included papers
or to acquire missing data from the authors of the
included papers.
Results
The electronic search of the three databases resulted in
4923 articles, of which 2411 articles were screened at
title/abstract level after excluding the duplicates. The full
text of 963 articles were retrieved and assessed for eligibil-
ity assessment and finally 505 articles were included in the
study. A PRISMA flow chart of the process is shown in
Figure 1.
Year
The rate of publication from 2002 to 2011 fluctuated
between 41 and 47 papers per year, except for the year
2004 which exhibited the lowest number of papers
(35 papers). However, the rate of publication increased
substantially to 68 papers per year in 2012 (Figure 2).
Country
There were 481 papers describing studies conducted in
single countries. The remaining 24 papers reported inter-
national studies in which the country of the clinical service
provider was different from that of the recipient. Papers
concerning single-country studies came from 29 countries,
with the US, Australia, Canada and the UK having the
greatest number of papers (Table 2). Nine countries
(Albania, Colombia, Jordan, Mexico, Pakistan, Romania,
Serbia, Northern Mariana Islands and Sa˜o Tome´ and
Prı´ncipe) were solely part of multi-national studies.
Figure 1. The process of identifying, screening and including
articles for the review.
Figure 2. Number of papers related to videoconferencing for
clinical purposes.
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Level of evidence
Non-randomised clinical trials represented the highest
proportion of the papers (57%), followed by RCTs, com-
parative studies and case series/case studies. There were 53
papers reporting other study designs, or not mentioning
the study design (Table 3).
Medical disciplines
Some papers focused on a single health condition or dis-
ease, whereas others included multiple diseases or did not
limit their study to particular diseases or health condi-
tions. In 217 papers, videoconferencing was used for a
single medical discipline. The most common single med-
ical discipline was mental health with 85 (39%) papers,
followed by surgery with 15 (7%) papers. The most fre-
quently researched single medical disciplines are shown in
Table 4. In 288 papers, the application of videoconferen-
cing was extended to more than one disease. In these
papers, mental health was the medical discipline under
study in the greatest number of papers (147; 13%),
followed by general medicine with 101 (9%) papers.
Type of care delivered
Videoconferencing was used for the delivery of different
types of patient care. In 286 papers the study design
focused on a single type of care, either acute, sub-acute
or chronic care. In the remaining papers, the intervention
comprised a combination of care types (Table 5).
Age group
In 225 (45%) papers, the intervention was targeted at a
specific age group. In the remaining 196 papers, more than
one age group was investigated. In 84 (16%) papers the
age group of the participants was not recorded. The dis-
tribution of the papers based on the age group of the
subjects is shown in Table 6.
Purpose
A total of 46 papers reported the use of videoconferen-
cing for a single purpose (diagnosis 38, screening 2,
Table 2. Countries with five or more papers.
No of papers Percentage
USA 184 36
Australia 71 14
Canada 56 11
UK 49 10
Sweden 16 3
Italy 12 2
Germany 12 2
Norway 9 2
China 9 2
Spain 8 2
Finland 7 1
New Zealand 5 1
Netherlands 5 1
India 5 1
Other countries 33 7
Multinational 24 5
Total 505 100
Table 4. Distribution of single-discipline studies.
Only disciplines with five or more papers are shown.
Number Percentage
Mental health 85 39
Surgery 15 7
General medicine 14 6
Cardiology 13 6
Neurology 12 6
Nursing 11 5
Emergency medicine 10 5
Speech pathology 8 4
Ophthalmology 5 2
Oncology 5 2
Ear, nose and throat 5 2
Dermatology 5 2
Other 29 13
Total 217 100
Table 3. Design of studies reported in the papers.
Number Percentage
Randomised controlled trial 80 16
Non-randomised clinical trial 286 57
Comparative studies without
concurrent controls
61 12
Case series, Case reports 25 5
Other/not specified 53 10
Total 505 100
Table 5. Type of care provided via videoconferencing.
Number Percentage
Acute 130 26
Sub-acute 86 17
Chronic 43 9
Combination of acute, sub-acute,
and chronic
222 44
Uncertain 24 5
Total 505 100
380 Journal of Telemedicine and Telecare 20(7)
 at UQ Library on November 19, 2014jtt.sagepub.comDownloaded from 
24
monitoring 2, counselling 2, management 1, follow-up 1).
In the remaining papers (459 of 505, 91%) the videocon-
ferencing was used for several purposes (Table 7). In add-
ition to the primary purposes mentioned above, in 314
papers videoconferencing was used for other non-clinical
purposes such as patient education (172), training other
health staff (49) and administration (48 papers).
New consultation or patient review
Videoconferencing was used for new patients in 180 (36%)
papers, for review patients in 40 (8%), or for both new
and review patients in 249 (49%) papers. In 35 (7%)
papers, it was not clear whether the patients were new
or review cases.
Health care providers and recipients
The majority of papers (314) reported a specialist doctor
as the health care provider via videoconferencing. There
were also nurses (100), psychologists (53) and GPs or
registrars (34). In 12 papers the qualification of the
health care provider was not clear. The recipients of video-
conferencing were the patients in 466 papers. In addition
to patients, patient family or carers, specialist doctors,
nurses and GPs were the other recipients of service.
Efficacy and effectiveness
In 423 papers (84%) the trial was categorised as an effi-
cacy study, i.e. the videoconferencing intervention was
investigated under controlled circumstances. The
remaining 82 papers (16%) represented effectiveness stu-
dies, i.e. the intervention was investigated under ‘real-
world’ conditions.
Attendance at videoconference
Patients were alone when participating in videoconfer-
ences in 103 (20%) papers. In other cases, the patient
was accompanied by a nurse (96, 19%), family member
or carer (28, 6%) or others (154, 30%). In 124 (25%)
papers it was not clear whether the patient was alone or
accompanied by others.
Setting
The setting of the care provider was mainly hospital
(273, 54%) or standalone clinics (140, 28%). In six studies
(1%), the healthcare provider was based at home and in
65 (13%) papers this setting was not mentioned. The
recipients of the videoconferencing were situated at hos-
pital (225, 45%), clinic (177, 35%), home (131, 26%),
nursing home (27, 5%) or other locations (22, 4%). In
20 (4%) papers, the setting of the recipient was not
specified.
Discussion
Peer-reviewed papers about the clinical applications of
videoconferencing were published continuously over the
study period. The trend in publication rate was similar
to that of telemedicine related papers in general. The dip
in the year 2004 and the steep increase in the year 2012
matches the pattern of publication rate in telemedicine
papers generally.3 However, the reason for these changes
is not known. The striking increase in the number of
papers in the year 2012 may reflect the improved avail-
ability of videoconferencing for a broader range of people,
including patients.
In the present review, more than one third of the papers
were from the US, followed by Australia, Canada and the
UK. These four countries contributed more than 70% of
the papers reviewed. In a previous study, these four coun-
tries were also found to have published the most papers on
telemedicine generally.3 Sweden, Norway and China
appear in the top ten countries with papers on videocon-
ferencing, but not among those with general telemedicine,
telehealth or e-health related papers, Table 8. This sup-
ports the general belief that the countries which have
populations isolated by harsh climate or long distances
are more interested in videoconferencing for clinical pur-
poses, compared to the non-clinical applications of tele-
health or e-health.
Only 80 of the 505 papers reviewed (16%) reported
randomised controlled trials. This reinforces the conclu-
sion of previous systematic reviews that have emphasized
the need for high quality studies in telemedicine.12–15
Mental health has been by far the most commonly
researched discipline with respect to the clinical use of
Table 7. Primary purpose of telemedicine intervention.
Number* Percentagey
Management 421 84
Diagnosis 339 67
Counselling 321 64
Monitoring 287 57
Screening 14 3
*the total number exceeds the number of papers reviewed because of
studies with multiple purposes.
ypercentages based on n¼ 505.
Table 6. Age groups of the subjects.
Number Percentage
Paediatric 87 14
Adult 100 20
Geriatric 38 8
Combination of age groups 196 39
Not specified 84 16
Total 505 100
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videoconferencing. However, disciplines such as surgery,
cardiology and neurology that may perhaps rely more on
physical examination appeared among the top five single
disciplines in the papers reviewed. This supports previous
findings that the inability of doctors to perform physical
examinations by videoconferencing, which may be per-
ceived as a drawback for telemedicine, is not a barrier
for providing clinical care at a distance.16
Adult patients were the most frequent age group of
participants in the papers reviewed, followed by paediat-
rics and geriatrics. Since video-based telemedicine services
are often established between two health care facilities,
and primarily operated by experienced staff rather than
the patient, concerns about technology acceptance and
ease of use for the patients are of lesser importance.17
Videoconferencing was mainly used for the manage-
ment of diseases rather than diagnosis, counselling or
monitoring of the patients. This mirrors the need for fre-
quent clinical appointments for people with chronic dis-
eases and supports the idea that a proportion of clinical
follow-up consultations can be delivered via
videoconference.18
In the majority of the papers reviewed, patients were
accompanied by nurses, family members or others.
However, in 20% of the papers, the patients were alone
when participating in the video consultation. Since video-
conferencing can be performed using mobile devices such
as smartphones, remote clinical encounters in future are
more likely to happen outside health care facilities.
Research is required on the use of mobile devices for clin-
ical videoconferencing, from both a provider and con-
sumer point of view.19
The majority of the studies were conducted in con-
trolled conditions and few studies were conducted in rou-
tine clinical care settings. Thus, the evidence of
effectiveness is somewhat limited and may not be general-
isable to other patients groups or settings. To be of most
practical value for clinicians and policy makers, studies
should have a pragmatic nature and consider external val-
idity (i.e. applicability beyond the immediate study condi-
tions) at the design stage.
In general terms, if the results of the studies are to have
practical implication for other researchers and clinicians,
the intervention must be thoroughly described, and the
logistic and technical features of their interventions
explained in sufficient detail. Unfortunately, not all studies
in the present review reported these details. Following the
CONSORT-EHEALTH guideline, though not specifically
designed for videoconferencing, could improve the report-
ing quality of the telemedicine papers and the generalis-
ability of their results.20
Conclusion
Videoconferencing has been used for various clinical pur-
poses in awide range of disciplines and settings. The present
review shows that disease management applications were
more common than diagnostic, counselling or patient
monitoring applications. All age groups were represented,
although most studies focussed on adults. Mental health
was the most commonly reported clinical area, confirming
that many evidence-based mental health interventions may
be provided effectively by video. Procedural disciplines, and
those requiring more direct physical examination, were less
common in the literature reviewed.
From a methodological perspective, there have been
shortcomings and inconsistencies in the reporting of find-
ings of research projects, which limit their replication. The
practical value of published papers would be improved by
following standard guidelines for reporting research pro-
jects and clinical trials. Future research could complement
the findings of the present study by thematic mapping of
the literature to identify and/or visualize the key concepts
of telemedicine.
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5. TECHNICAL ASPECTS OF VIDEOCONFERENCING FOR CLINICAL 
PURPOSES: A REVIEW OF THE LITERATURE 
5.1. Introduction 
Audio-visual quality of a VC session is a major determinant of usability and satisfaction; both 
for recipients and providers. From a technical perspective, parameters such as bandwidth, 
frame rate, image size, resolution, and levels on camera control are determinants of the 
quality of a VC session. Quality of video and audio could be of different importance based on 
the medical specialty for which videoconferencing is used. Disciplines such as dermatology 
and radiology require much higher quality of image comparing to psychiatry, for example. 
Although it is difficult to rate the quality of videoconferencing encounters simply by 
describing the type of device and connectivity, these characteristics still do provide an 
indication of the quality of voice and image. For the purpose of this study, we categorise the 
VC solutions into two main groups: High quality VC using dedicated equipment (Codec) and 
high speed connections such as ISDN or broadband network, and Low-medium quality using 
other solutions including PC- or Web- based VC, video phone, or mobile phone, via various 
connectivity solutions such as DSL, dial-up and mobile cellular network. 
Videoconferencing has been the subject of increasing number of peer-reviewed publications 
over the past decade, but we found no review on the technical aspects of VC and the trend of 
changes in equipment used for clinical VC over time. The aim of this study was to review and 
summarise the equipment used for VC for clinical purposes and reveal the trend of changes, 
if any, during the past decade.  
5.2. Methods 
Based on the findings of the previous review study (Chapter 4), papers which mentioned 
technical information regarding videoconferencing were explored to identify the hardware, 
software, networking, and the bandwidth used for videoconferencing. 
 In order to illustrate the trend of changes in the bandwidth used for VC, we categorised the 
bandwidth into three categories: 
• Low-speed: less than 384 kbit/s 
• Medium: between 384 kbit/s – 1 Mbit/s 
• High-speed: more than 1 Mbit/s 
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384 kbit/s is regarded as the lowest recommended bandwidth for videoconferencing of an 
acceptable quality, and bandwidth of more than 1 Mbit/s is regarded as high-speed 
connection in many papers. 
5.3. Results 
The search in the three online databases resulted in 1822 unique records. Two authors 
screened the records at Title/Abstract level and selected 906 articles for assessing the full-text 
for eligibility. Finally 505 articles were included in this review. 
5.3.1. Trend of publication with technical information 
78 papers out of 505 did not provide any information on the equipment used for 
videoconferencing. Six papers mentioned the equipment info for just one party, (one for 
provider side and five for recipient side), and 422 (84%) papers mentioned the type of 
equipment used in their research. The trend of papers with adequate technical information 
varied between 74% in 2002 and 95% in 2009, but did not show any specific pattern over the 
years under review (Figure  5-1). 
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Figure  5-1 Proportion of papers providing technical information of videoconferencing over time 
5.3.2. Equipment 
The equipment used for videoconferencing was not mentioned in 85 papers (17%) articles. 
Dedicated VC codec was the most frequently used equipment both at provider end (224) and 
recipient end (227), followed by computer/laptop/notebook. The frequency distribution of the 
equipment used by the providers and the recipients are summarised in Table 1 and Figure 2. 
The number of papers reporting the equipment used for videoconferencing does not show any 
trend over time except for a slight increase in the years 2011 and 2012 for mobile/smart 
phone both for providers and recipients (Figure  5-2). 
 
 
Figure  5-2 Equipment used by providers and recipients for videoconferencing by year 
 
5.3.3. Bandwidth 
The bandwidth of videoconferencing was not mentioned in 233 (46%) of the studies. The 
Trend of bandwidth used for VC over time is shown in Figure  5-3. The number of articles 
0%
10%
20%
30%
40%
50%
60%
70%
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Provider equipment % 
VC Codec
PC/Laptop/Notebook
Videophone
Mobile/Smart phone
0%
10%
20%
30%
40%
50%
60%
70%
80%
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Recipient equipment % 
VC Codec
PC/Laptop/Notebook
Videophone
Mobile/Smart phone
 31 
that have not mentioned the bandwidth used for the study has increased from 32% in 2002 to 
68% in 2012. 
 
Figure  5-3 Number of papers reporting the bandwidth used for videoconferencing over time  
5.4. Discussion 
A large proportion of peer reviewed papers on using videoconferencing for clinical purposes 
have not provided the technical information of their intervention. There was a significant 
increase in the number of papers in the year 2012. The most widely used hardware for 
videoconferencing are dedicated VC codecs and personal computers (desktop, laptop, or 
notebook). Starting in 2005, research studies have used mobile/smart phones to establish 
videoconferencing for clinical purposes. A range of bandwidth has been used in the studies, 
but over time the use of low bandwidth connectivity has declined and a greater proportion of 
the papers have reported using medium bandwidth (384 Kb/s – 1 Mb/s) for 
videoconferencing. Nevertheless, during the past eleven years, a lower proportion of papers 
are providing information on the bandwidth. Reliability and the quality of service are other 
concepts related to the connection speed, which are highly dependent on the technology used 
for establishing the link between health care providers and recipients.21 These concepts are 
often beyond the technical expertise of clinical researchers. Considering the rapid change in 
the ICT technology in the past decade that affects the technical availability and quality of 
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videoconferencing, there is a need for more stable indicators, apart from hardware and 
software, when reporting the results of research studies for clinical purposes. 
Research shows that the quality of video and audio in video consultations is significantly 
correlated with the content of communications exchanged between health care 
professionals.22 Image freezing and transmission delays are among the technical challenges 
that require solution in synchronous telemedicine, in particular in applications that heavily 
rely on visual information such as tele-sonography.23 When image quality is a critical factor, 
high definition video transmitted over super-fast networks should be considered. 
Uncompressed High Definition technologies, though not yet ready for broad deployment, can 
be used in disciplines such as teledermatology in which  standard definition video is not 
satisfactory.24 Results of this review showed that a very low proportion of papers have 
mentioned frame rate and image quality of their videoconferencing solutions. Although the 
overall quality of videoconferencing depends on many factors,25 reporting a few basic 
settings of videoconferencing (such as frame rate) under study can roughly indicate the 
quality of video and audio experienced by the clinicians and/or patients during a clinical 
video visit. 
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Section 2: Preliminary Studies 
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6. PROCESS ANALYSIS OF CONVENTIONAL DIABETES 
CONSULTATIONS  
6.1. Paper Information 
The review of the literature showed that there is no previously published report on the 
feasibility of videoconferencing for clinical consultation dealing with patients who have 
diabetes.  
By understanding the characteristics of the diabetic patients who are referred to an 
endocrinologist for specialty consultation, as well as the procedures and components of such 
consultations, it would be possible to identify the consultations that, either entirely or in part, 
can be performed remotely via videoconferencing. 
This study was designed to provide the basic information needed for a clinical trial on the 
reliability of video consultation for diabetes. The aim of this study was to quantitatively 
analyse the process of care which is provided by endocrinologists in an outpatient clinic. 
The following paper has been published in the Diabetes and Technology and Therapeutics 
journal (2013), Volume 16, Issue 1, pages 8-14. The candidate, Farhad Fatehi, was primarily 
responsible for conducting the research and writing the manuscript. The paper's co-author, 
Leonard C Gray and Anthony W Russell, contributed to this paper in various aspects as listed 
in the preliminary pages of this thesis 
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A Clinimetric Study of Outpatient Diabetes Consultations:
The Potential for Telemedicine Substitution
Farhad Fatehi, MD, MSC,1,2 Leonard C. Gray, MD, PhD,1,3 and Anthony W. Russell, MD, PhD4,5
Abstract
Background: The purpose of this study was to identify the clinimetric characteristics of specialist outpatient consultations for
people with diabetes and to evaluate the possibility of providing such consultations remotely using telemedicine.
Materials and Methods: The process of care was analyzed during the specialist consultations provided by five endocrinol-
ogists in a tertiary hospital diabetes outpatient clinic. The specialists’ opinion of the possibility of providing each consultation
remotely was also sought.
Results: In total, 50 consultations were analyzed. The patients had type 1 and type 2 diabetes in 28% and 64% of the cases,
respectively; 68% had at least one diabetes complication. Diabetic neuropathy was the most prevalent (42%) complication.
Physical examination was not performed by the specialists in 34% of cases. General foot inspection, the most frequent
examination, was performed in 54% of the consultations. After ‘‘general advice,’’ ordering laboratory tests was the most
frequent recommendation (80%), followed by adjustment of an insulin regimen (52%). In 86% of consultations, the specialists
believed that it would have been possible to provide that consultation remotely via videoconferencing to a patient with the
general practitioner present. In their opinion, communicating with the patients through e-mail was the least possible alter-
native means of providing the consultations.
Conclusions: Endocrinologists with little telemedicine experience believe that a considerable proportion of outpatient spe-
cialty consultations for people with diabetes can be provided remotely via videoconferencing. The clinimetric analysis of 50
consultations supports this opinion.
Introduction
With the increasing rate of obesity and the relativeshortage and cost of healthcare providers, the provi-
sion of appropriate care for diabetes patients has become a
major challenge for many countries.1–3 Tight control of blood
glucose has been shown to prevent or delay development of
diabetes complications4–6; however, the majority of patients
do not receive standard health checks,7 and more than 30% of
people with diabetes fail to achieve their target level of gly-
cemic control in general practice.8,9
Several strategies have been suggested for improving the
outcome of managing people with chronic illness—ready
access to necessary expertise is one of them.10 However, ac-
cess to specialty care is not possible for all patients all of the
time. Geographical, financial, social, and cultural barriers
limit access to specialists for patients.11,12 Limiting factors
could be enforced from the provider side as well. A propor-
tion of subspecialists, including endocrinologists, cannot ac-
commodate patients with physical mobility impairment, thus
imposing more limitations to access to specialty care.13 New
methods are needed for improving timely and appropriate
access of patients to specialist advice for managing chronic
diseases.14 Similarly, primary care providers also benefit from
access to specialists for education and up-skilling.15
In response to growing demand for care with decreasing
availability of personnel, information and communications
technology has the potential for improving access to health-
care services and lowering costs. Telemedicine services have
been successfully introduced in medical disciplines such as
pathology16 and radiology,17 where in-person interaction
between the patient and the specialist is not essential. How-
ever, scientific evidence on the application of telemedicine
solutions for the clinical management of chronic disease, in-
cluding diabetes, is weak and contradictory.18 Although there
are reports that telemedicine case management of diabetes
effectively improves glycemic control, levels of blood lipids,
and blood pressure,19 most of the publications to date on
telemedicine for improving diabetes care describe various
interventions for monitoring the blood glucose level,
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adherence to the treatment plan, patient education, and mo-
tivational support of the persons with diabetes,20 but not the
process of consultation with diabetes specialists. Thus it is not
possible, based on the current literature, to comment on the
feasibility, acceptability, safety, and accuracy of telemedicine
for diabetes specialty consultation.
To evaluate the possibility of providing remote consulta-
tion for people with diabetes, it is necessary to clearly identify
how a traditional consultation is performed. By understand-
ing the nature of referrals, the profiles of the patients and their
clinical conditions, the content of the interview, the proce-
dures, and the outcomes, it may be possible to identify those
consultations that, entirely or in part, might be substituted
with a telemedicine modality, should the patient live in a
community with limited access to specialists. The American
Diabetes Association considers four components for a com-
prehensive diabetes evaluation: medical history, physical ex-
amination, laboratory evaluation, and referrals.21 Of these
components, physical examination appears to be the only one
that is challenging to perform remotely via telemedicine.
However, the limitations associated with telemedicine highly
depend on the mode of interaction and the equipment used
for remote provision of care and exchange of information.
In asynchronous telemedicine (or store-and-forward tele-
medicine such as e-mail) the provider and the consumer do
not interact in real time, so there is always a delay between
sending a request and receiving the response. This time lag
logically opts out this mode of telemedicine for emergency
consultations. Moreover, basic e-mails are traditionally used
to convey messages in text format, although there is an in-
creasing capability with most of the e-mail service providers
for attaching audio, image, or video files to the e-mails in
order to enrich the content of the messages. In contrast, in
synchronous (or real-time) telemedicine the provider and the
consumer interact with each other in real time, so theoretically
there is no time lag in communication between the local and
remote parties. Synchronous solutions are categorized based
on themodality used for communication, ranging from online
text chat, to telephone call, and then to interactive video call
(videoconference). Although a telephone call is the most
available means of telecommunication worldwide, video-
conferencing has the superiority of incorporating video over
voice, thus capable of communicating visual information and
nonverbal cues. Considering the four techniques used in a
classic physical examination (i.e., inspection, palpation, per-
cussion, and auscultation), videoconferencing can provide the
users with the possibility to inspect and auscultate (to some
extent), but a telephone call can be used only for auscultation
at the best, and online chat can help with none of them.
Clinimetrics is a methodological discipline concerned with
measurement issues in clinical medicine.22 From the clinical
point of view, different medical disciplines rely differently on
findings from physical examinations. For instance, decision
making in general surgery disciplines mostly depends on
palpation and percussion, in cardiology on auscultation, and
in ophthalmology on inspection. Thus the impact of findings
through physical examinations on decisions made by clini-
cians needs to be assessed based on the discipline under
question. Nevertheless, physical examination can be safely
performed by other healthcare professionals such as a general
practitioner (GP) or a nurse on behalf of the specialist. It has
been shown that collaborative management of diabetes by a
multidisciplinary team is effective in achieving and main-
taining glycemic control.23
This study was designed to assess the possibility of pro-
viding outpatient referral specialty consultations remotely.
We adopted two approaches: (1) conceptualization and
analysis of the process of care during an outpatient specialist
visit for diabetes management and (2) seeking the special-
ists’ opinion on the suitability of each consultation to be
conducted remotely via telemedicine for several in-person
diabetes consultations. The specialists’ opinion informs us of
an estimate of the percentage of the referral diabetes patients
who could be consulted on remotely using a range of tele-
medicine solutions in different settings (i.e., where a GP is
available, a nurse is hosting the remote consultation, or the
patient is alone). Moreover, the process analysis of diabetes
specialty consultations in an outpatient referral clinic en-
ables us to identify various elements of such consultations.
These elements can then be evaluated, where required, for
the possibility of being conducted remotely by a GP, nurse,
or trained health professional under supervision of the
specialist.
The objectives of this study were:
 To systematically conceptualize the traditional in-person
diabetes consultation provided by endocrinologists in an
outpatient setting
 To provide a profile of patients referred to a specialist
outpatient diabetes clinic
 To identify the frequency of various components of
typical specialty consultations for diabetes care and
recommendations made for each patient that might
present challenges if substituted with telemedicine
 To assess the endocrinologist’s opinion on the possibil-
ity of using telemedicine instead of in-person consulta-
tion for each case of diabetes consulted
Materials and Methods
This observational study was conducted in the outpatient
diabetes clinic of the Princess Alexandra Hospital, Brisbane,
Australia. This is a tertiary referral hospital in the south met-
ropolitan area of Brisbane. This hospital serves both its local
population (over 1 million people) and the patients referred by
regional hospitals and doctors. Around 75% of the patients
seen in the diabetes outpatient clinic are referred by GPs, and
the other 25% are internal referrals fromother specialistswithin
the hospital. All the consultant endocrinologists in the clinic
were approached and asked to participate. They were re-
quested to complete a questionnaire for each of the consulta-
tions for adult patients with diabetes in two clinic sessions.
Consultations for patients younger than 18 years of age or
patients with severe audio/visual disability were excluded.
The instrument used in this study was a questionnaire that
was developed by a panel of endocrinologists who attended
at the Princess Alexandra Hospital outpatient diabetes clinic,
which reviews patients with diabetes referred from their GP.
They were familiar with telemedicine solutions to various
extents. The questionnaire comprised five sections: (1) pa-
tient’s characteristics, (2) reason for referral, (3) procedures
and findings, (4) detailed management plan, and (5) special-
ist’s opinion on the possibility of providing the consultation
remotely (Supplementary Fig. S1; Supplementary Data are
available online at www.liebertpub.com/dia). Another
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questionnaire was administered to assess the extent to which
the specialists were familiar with and used information
technology in their routine work.
The specialists’ opinion was sought on the possibility of
providing each consultation remotely in five different sce-
narios: the patient alone; the patient with a GP; a GP without
the patient present; a practice nurse with the patient; and a
diabetes nurse educator with the patient. In each scenario,
four modalities of telemedicine were proposed: telephone,
e-mail, Internet video chat such as Skype (Microsoft,
Redmond, WA), and high-definition videoconferencing (i.e.,
using dedicated videoconferencing equipment).
Data were entered into Microsoft Excel for producing the
descriptive statistics and then exported to R statistical soft-
ware24 for analysis. Absolute numbers and percentages were
used for presenting the demographic and baseline data. Lo-
gistic regression analyses were used to examine the predictive
power of patients’ age, type of diabetes, performance of
physical examination, and existence of any diabetes compli-
cation on the specialists’ opinion of the possibility of provid-
ing the consultation via telemedicine. No honorarium was
offered to the participating specialists. The Human Research
Ethics Committee of Queensland Health approved the study
(protocol number HREC/11/QPAH/583–15/11/2011).
Results
Fifty consultations performed by five consultant endocri-
nologists in the Princess Alexandra Hospital outpatient dia-
betes clinic were analyzed. Each consultant completed
between eight to 12 questionnaires in two clinical sessions.
Specialists’ profile
Five endocrinologists (three male and two female) partici-
pated in this study. The average experience of medical prac-
tice was 21.8 years (range, 12–31 years; SD, 8.7 years). They all
used e-mail regularly in daily life, for discussing clinical
problems with professional colleagues, and for interacting
with their patients. Although just one of them was using
videoconferencing for the purpose of medical practice, they
all reported part of their practice could be conducted via video
consultation.
Demographics
The age of the patients ranged from 21 to 87 years
(mean – SD, 54 – 17 years), and 54%weremale.More than half
of the patients lived within 20 km of the clinic, and only two
patients (4%) traveled more than 100 km to attend their ap-
pointment. Of 50 patients consulted on, 14 (28%) had type 1
diabetes, 32 (64%) patients had type 2, and the remainder (8%)
had other types of diabetes. Patients’ demographic charac-
teristics (i.e., age, gender, type, and duration of diabetes) were
statistically similar among the specialists.
Reason for referral
The majority of patients (n = 46; 92%) had previously been
seen in the clinic andwere scheduled for review appointments
(review patients), and only four patients (8%) were referred
for the first time (new patients). The new patients were re-
ferred to the clinic for management of (1) poor glycemic
control, (2) diabetes complications, or (3) macrovascular risk
factors. Prior to the consultation, 38 (76%) patients were tak-
ing insulin, and 26 (52%) were taking oral hypoglycemic
agents. Thirty four (68%) patients presented with at least one
diabetes complication. Neuropathy (42%) was the most
prevalent complication. Nephropathy, retinopathy, ischemic
heart disease, and diabetic foot ulcer were identified in 38%,
36%, 20%, and 8% of the patients, respectively.
Procedures and findings
The length of consultations varied from 15 to 60min
(mean– SD, 28 – 11min). The specialists performed no phys-
ical examination in 17 (34%) cases. All new cases had a
physical examination. Of the 33 cases in which a physical
examination was performed, no important signs that would
alter management were detected in 16 cases. Feet and
Table 1. Type of Examinations Performed
and Frequency of Important Signs Detected
by the Specialists (n = 50)
Number of patients with
Examination
Each
examination
performed
(%)
Important sign
detected in physical
examination
(% of those examined)
Feet
General inspection 27 (54%) 7 (25.9%)
Assessment of pulses 26 (52%) 4 (15.4%)
Neurological exam 23 (46%) 7 (30.4%)
Cardiovascular 19 (38%) 3 (15.7%)
Abdominal 19 (38%) 1 (5.2%)
Respiratory 17 (34%) 0
Injection sites 14 (28%) 6 (42.8%)
Neurological 11 (22%) 1 (9.1%)
Eyes 3 (6%) 1 (33.3%)
Other 2 (4%) 1 (50%)
Table 2. Recommendations Made by the Specialists
for the Patients’ Management Plans (n = 50)
Recommendation
Number
of patients (%)
Laboratory
Order lab test(s) 40 (80%)
Order other diagnostics (e.g., imaging) 8 (16%)
Medicationa
Initiate insulin 0
Initiate or titrate hypoglycemic
agents apart from insulin
8 (16%)
Initiate or titrate a drug for
cardiovascular risk factor reduction
14 (28%)
Adjustment of insulin regimen 26 (52%)
No change in medication 16 (32%)
Referral
Refer to another specialist 9 (18%)
Refer to allied health 15 (30%)
Arrange hospital admission 2 (4%)
General advice 46 (92%)
aThe percentages do not add up to 100% because of cases with
more than one medication change.
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injection sites had the highest number of important signs
detected during the physical examination. The specific phys-
ical examinations performed on the patients as well as the
frequency of important signs detected by the specialists are
summarized in Table 1. The performance rate of physical
examination among the specialists was significantly different
(Pearson’s v2 test, P < 0.01). One specialist physically exam-
ined all the patients consulted, whereas other specialists
performed physical examination just for a proportion of their
patients (Fig. 1).
Management plan
In 16 cases (32%) no medication change was advised. After
‘‘general advice,’’ ordering laboratory tests and adjustment of
an insulin regimen were the most frequent recommendations
given in the consultations (Table 2). A follow-up visit was
arranged for 47 (94%) patients, ranging from 1 to 52 weeks
later (mean – SD, 19 – 13 weeks).
Specialists’ opinion on the possibility of providing
the consultation remotely
The specialists reported that a GP or a trained nurse could
perform the physical examination and report to them in 47
(94%) or 29 (58%) of the cases, respectively. From the spe-
cialists’ point of view, it was possible to provide the same
consultation via high-definition videoconferencing in 86% of
the cases if the patient was accompanied by a GP. The spe-
cialist considered that e-mail was the least favored means to
provide a remote consultation (Table 3). Logistic regression
analyses did not show any significant association between the
potential explanatory effects of the patients’ age, gender, type
of diabetes, presence of diabetes complication, or perfor-
mance of physical examination with the specialists’ opinion
on the possibility of remote consultation via videoconferenc-
ing. Generalized linear mixed-effects modeling with the spe-
cialist as a random effect did not improve the models fitted in
logistic regression analyses (data not shown).
Discussion
Physician–patient communication and its impact on the
patient’s health outcome have been researched in several
studies, both in conventional in-person consultations25,26 as
well as telemedicine encounters,27 but no studies were iden-
tified in the literature on clinimetric analysis of specialty
consultation for chronic diseases and in particular diabetes.
Although communication skills of the physicians and psy-
chological factors have been shown to influence the outcome
of medical consultations, little is documented about the var-
ious components of outpatient specialty consultations and
hence the possibility of provision of such services remotely via
telemedicine modalities. To our best knowledge, this is the
first report on the clinimetric characteristics of specialty out-
patient consultations for diabetes management.
The contribution of history taking and physical examination
in diagnosis and management of health conditions has been
traditionally highlighted by several studies.28,29 However,
FIG. 1. Performance of physical examination by the five specialists during consultations.
4 FATEHI ET AL.
42
physicians’ estimate of the most important components of
clinical encounters varies significantly by the disease. For ex-
ample, in a survey of 313U.S. physicians, 95% estimated labo-
ratory tests as the most important component in clinical
encounters for themanagement of diabetes, followed by patient
history (19%) and physical examination (9%). But for manage-
ment of rheumatoid arthritis, patient history and physical ex-
amination received the highest estimation by 74% and 65% of
the physicians, followed by 19% for laboratory tests.30
The results of this study show that it is possible, from the
specialists’ point of view, to substitute video teleconsultation
for a significant proportion of in-person specialist diabetes
consultations. A well-known limitation of telemedicine—
inability to perform a complete physical examination—did
not appear to be a barrier withmany diabetes review patients.
Evidence regarding the impact of physical examination on the
outcome of a specialty consultation for diabetes is scant. It has
been shown that the contribution of physical examination to
the diagnosis of conditions like dementia is not significant
if the results of laboratory examinations and imaging inves-
tigations are accessible.31 Also, it is feasible to conduct phys-
ical examination remotely through videoconferencing by
a trained health worker under supervision of a specialist.
Depending on the modality used for telemedicine, there will
be various degrees of limitations on performing physical ex-
amination remotely. Videoconferencing has been shown to be
more effective and more acceptable compared with a tele-
phone call for clinical purposes.32
Thirty-four percent (n= 17/50) of the consultations in this
study were provided without any physical examination by the
specialists. This indicates that the history and clinical data
seemed to be sufficient for the specialist to make a final rec-
ommendation in a considerable proportion of outpatient visits.
This observation suggests that it could be possible to predict
which patient needs physical examination during a diabetes
specialty consultation. In fact, most of the comprehensive
physical examinations for the management of diabetes have
been recommended to be performed on an annual basis.21 Our
finding supports the anecdotal evidence that the specialists do
not need in all consultations to physically examine the patient
to give advice on the patient’s management plan. Moreover,
the significant difference between the practice styles of the spe-
cialists in terms of performing physical examination for their
patients suggests the effect of personality or habits of individ-
ual physicians on their clinical practice. It is also noteworthy to
mention that the percentage of consultations in which physical
examination is not performed could have been even higher
than what we are reporting. It has been evident that physicians
may temporarily alter the quality of care when their practice is
being surveyed by a researcher (the Hawthorne effect).33
In 32% of the specialist consultations, there was no ad-
justment made to the current treatment regimen. The most
common change in therapy was adjustment of insulin dose.
All changes in management could theoretically be conveyed
and acted upon remotely. In Australia, Medicare Benefits
Schedule item numbers are available for reimbursement for
remote consultations rendered by specialists via videocon-
ferencing for patients in remote, regional, or outer metropol-
itan areas. Similar item numbers were also introduced for the
patient-end services provided by GPs, nurse practitioners,
midwives, or other eligible practitioners during the video
consultation with the specialist. However, video consultation
is potentially a more expensive solution than conventional
consultation at present, not only for the needed equipment
and technical requirements, but also for administration and
coordination. Because of the financial burden of video consul-
tation, especially in the countries where remote consultations
are not reimbursed, deciding on this option needs to be in-
formed by proper economic evaluations. A systematic review
of real-time videoconferencing for telehealth services showed
mixed economic results for rural service delivery.34
Unsurprisingly, asynchronous telemedicine and consulting
the patient directly with no healthcare provider present were
less desirable as a substitution for in-person consultations
from the specialists’ point of view. Using e-mail for interacting
with the patient without any GP or nurse involved was the
least favored configuration for the provision of the consulta-
tions remotely (8%). Provision of the consultation via high-
definition videoconferencing where the patient was accom-
panied by aGP received the highest rate of acceptability (86%)
to replace traditional in-person consultations, according to
the specialists’ opinion. There was some reluctance to do the
video consultation with the patient alone. Although just one
of the study specialists had ever used videoconferencing for
clinical practice, all reported that part of their medical practice
could be done remotely via video. No statistically significant
relationship was seen between the level of specialists’ infor-
mation technology skills and experiences and their opinion on
the possibility of using videoconferencing for remote con-
sultation. All the recommendations that specialists made for
the patients are capable to be made remotely should the legal
and administrative measures allow for such interactions.
Our study raised several questions for future research.
First, which factors have the highest predicting power on the
suitability of a clinical consultation to be provided remotely?
Second, acknowledging that a remarkable proportion of
specialty consultations for diabetes patients are thought to be
able to be provided from a distance, what would be the op-
timal model of care for exploiting telemedicine for manag-
ing diabetes? Would it be safe and reliable to conduct an
Table 3. Possibility of Providing the Consultation Remotely from the Specialists’ Point of View (n = 50)
Setting Telephone E-mail Internet video chat HD VC
The patient alone at the remote site 17 (34%) 3 (6%) 20 (40%) 24 (48%)
Case presented by a GP without the patient present 23 (46%) 4 (8%) 23 (46%) 26 (52%)
A GP with the patient present 29 (58%) 5 (10%) 30 (60%) 43 (86%)
A practice nurse with the patient present 21 (42%) 5 (10%) 22 (44%) 34 (68%)
A diabetes nurse educator with the patient present 23 (46%) 5 (10%) 24 (48%) 37 (74%)
GP, general practitioner; HD VC, high-definition videoconferencing.
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in-person consultation once a year and perform the inter-
vening review consultations remotely?
This study has several limitations that make it difficult to
generalize the results. The number of consultations studied is
relatively low. Also, the setting used for this study was an
outpatient diabetes clinic in a tertiary teaching hospital. This
setting may not be representative of all diabetes specialty
consultations, especially in countries that have not im-
plemented a referral system for the patients to receive a spe-
cialty opinion. Another limitation of the study is that we
acquired specialists’ opinion on the possibility of using tele-
medicine for each case after they had consulted on the patient.
In reality, the decision on suitability of each case for remote
consultation needs to be made prior to the consultation. It is
not clear to what extent these opinions would match those
acquired without patient contact and just relying on the pa-
tient records and GP referral note.
Conclusions
Physical examination was not performed for almost one-
third of patients during their specialist consultation. All types
of recommendations made in the consultations (i.e., labora-
tory orders, changes in medication, and referrals) can be en-
acted remotely. Specialists with little telemedicine experience
report that a considerable proportion of outpatient specialty
consultations for people with diabetes can be provided
remotely via videoconferencing. Telemedicine should be a
viable and safe option to deliver specialist diabetes services to
rural and remote areas.
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7. PROCESS ANALYSIS OF VIDEO CONSULTATIONS IN A TELE-
ENDOCRINOLOGY CLINIC  
7.1. Paper Information 
Telemedicine can improve access to care, especially for people who are living in remote and 
rural areas. It is a feasible mode of health care delivery for people with chronic conditions, 
who need ongoing care often for a long time. Despite the growing number of real-time 
telemedicine services using videoconferencing in many countries, little has been published on 
the processes and procedures of video consultations. Most of the research to date on video 
consultation is focused on the verbal contents of the interviews, or behaviours of each party. 
Nothing has been published on the clinical nature of video consultations. 
The aim of this study was to examine the practice of video consultation in a tele-
endocrinology clinic where endocrinologists consult diabetic patients remotely, and analyse 
the consultations provided videoconferencing. 
The following paper has been published in the Journal of Telemedicine and Telecare (2013), 
Volume 19, Issue 7, pages 379-382. The candidate, Farhad Fatehi, was primarily responsible 
for conducting the research and writing the manuscript. The paper's co-author, Leonard C 
Gray and Anthony W Russell, contributed to this paper in various aspects as listed in the 
preliminary pages of this thesis. 
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Telemedicine for clinical management
of diabetes – a process analysis of
video consultations
Farhad Fatehi1,2, Leonard C Gray1,3 and Anthony W Russell4,5
Summary
We analysed 56 video consultations provided in a 5-month period by two endocrinologists from the tele-endocrinology clinic of
a tertiary teaching hospital in Brisbane. The patients were suffering from type 1 or type 2 diabetes, and 41% of them had at least
one diabetic complication. Their mean age was 51 years and 45% were female. The consultations were provided to ten cities
located 210–1800 km from Brisbane. A questionnaire was developed for analysing the video visits. It comprised 26 questions,
arranged in six sections: (1) Patient characteristics, (2) Reason for referral, (3) Procedures and findings, (4) Recommendations,
(5) Telehealth logistics, (6) Consultant’s opinion. In 66% of consultations a nurse accompanied the patient. The specialist
requested the nurse to perform a physical examination in 18% of these cases. No change in medications was made in 36%
of the consultations. The most frequent recommendations were requesting laboratory tests (75%), insulin dose adjustments
(39%) and referrals to an allied health professional (13%). Out of 56 consultations, the specialists indicated the need to perform
a physical examination for 12 patients that was not possible remotely. However, they requested an in-person (face-to-face) visit
for three patients. Nevertheless they believed that in 34% of the cases they could have made a better decision if the consultation
had been in-person. Video consultation can substitute for a large proportion of in-person specialist consultations for people
with diabetes who are referred to endocrinology specialists.
Accepted: 1 September 2013
Introduction
Managing diabetes is complex and costly, and remains a
challenge in many countries. Adequate access to high
quality care is required to improve the outcome of this
disease, but there is marked disparity in access to care
between urban and rural residents.1 Residents of rural
and remote areas suffer from lower quality of diabetes
care.2
Telemedicine can improve access to health care ser-
vices, especially for people living in remote and rural
areas. Despite the growing popularity of telemedicine
for improving access to care, little has been published
on the nature of consultations provided remotely via
videoconferencing. Several studies have analysed physi-
cian-patient interactions, but they have all focused on the
content of verbal interactions3,4 or the behaviours of
each party.5,6 We are not aware of studies on the process
and elements of teleconsultation from a clinical point
of view.
The aim of the present study was to examine the prac-
tice of using videoconferencing for remote consultation of
people with diabetes who were referred to an endocrin-
ology specialist by their general practitioner (GP), and
analyse the process of care provided for them.
Methods
The consultations provided by two specialists in the tele-
endocrinology clinic of the Princess Alexandra Hospital
(PAH) were studied. The endocrinologists were asked to
complete a questionnaire for all the diabetic patients they
saw remotely in eight consecutive clinic sessions, from
February to June 2013.
A telehealth studio was established in 2009 in this clinic
as part of the state’s telehealth network. The clinic pro-
vides specialist consultations through videoconferencing
to remote and rural cities in Queensland, as far as
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2000 km from Brisbane (Figure 1). The telehealth studio in
the diabetes clinic is equipped with a videoconferencing
unit (990MXP, Tandberg) and an 81-cm flat-screen dis-
play. The unit provides a wide-angle view of the room,
and the camera can be controlled locally by the provider
and remotely by the recipient (Figure 2). Remote sites are
equipped with similar devices.
Administration and coordination
The patients were normally referred to the diabetes tele-
health clinic by their GP. A diabetes nurse educator
checked the patients’ records and contacted the patients
one week before the telehealth appointment to remind
them of the forthcoming video consultation and the neces-
sity for some blood tests. At the remote site, a nurse often
accompanied the patient. She provided the patient’s latest
clinical data, if not communicated beforehand, and per-
formed any physical examinations under the direction of
the specialist if required.
The patients’ data were accumulated and maintained
partly in hardcopy at the provider site and partly electron-
ically through an electronic patient record which is access-
ible through the Queensland Health IT network. After a
series of specialist consultations, when satisfactory blood
glucose level achieved, the patient was referred back to the
GP for regular follow-up. Ethics permission was not
required for the study.
Questionnaire
A questionnaire was developed for analysing the video
consultations. It comprised 26 questions, arranged in six
sections: (1) Patient characteristics, (2) Reason for refer-
ral, (3) Procedures and findings, (4) Recommendations,
(5) Telehealth logistics, and (6) Consultant’s opinion.
The questions were developed by observing conventional
diabetes consultations and seeking advice from a panel of
experts in telemedicine, each with more than five years of
experience with clinical videoconferencing. The question-
naire was pilot tested in four video consultations and
modifications were made to the questions as suggested
by the specialists and the researchers.
Analysis
To examine any associations between the characteristics
of the patients and the specialists’ perceived suitability for
videoconferencing, we carried out a cross-tabulation using
a standard package (SPSS, version 21). The chi-squared
test was used to test for significance.
Results
A total of 56 video consultations were analysed. The
patients were aged 14–81 years (mean 51). The character-
istics of the patients are summarised in Table 1. Of the 56
video consultations, 46 (82%) were review consultations
and 10 (18%) were new consultations. In 37 (66%) cases,
the patient was accompanied by a nurse whereas in 16
(29%) cases the patient was alone or with a family
member at the remote site. In three cases, the patient
was not present at the consultation and the case was dis-
cussed with a nurse or a family member.
Physical examination
In 49 consultations (88%) no physical examination was
performed. In seven cases, the nurse physically examined
Figure 1. The locations of the cities with more than two video
consultations.
Figure 2. The specialist and case coordinator in the telehealth
studio at the Princess Alexandra Hospital in Brisbane.
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injection sites, patients’ feet and cardiovascular system as
requested by the specialist and reported back to him. In
three out of seven patients for whom the specialist asked
for a physical examination, a new important sign was
detected that it was believed would influence the manage-
ment plan.
Management of the patients
The patients’ management plan was confirmed by the spe-
cialists in 21 (37%) of the consultations with no change
needed. In the remaining 35 consultations, the medica-
tions of the patient were changed in terms of initiation,
dose adjustment, change regimen or cessation of one or
more medicines (Table 2). Apart from medications, the
specialists made several recommendations for the patients
as shown in Table 3.
Follow-up
The specialists arranged for a follow-up visit through
video consultations for 48 (86%) patients. The follow-up
consultations were requested for the following 2–52 weeks
(mean 11). For three patients (5%), the specialists needed
to arrange an in-person consultation for optimum man-
agement of their condition.
Technical performance
During the 56 consultations, one video problem occurred
(loss of video during the consultation). No audio, connect-
ivity or other type of technical problem occurred.
Access to clinical data
The specialists had access to the patients’ clinical data in
various forms such as hard copy (25; 45%), electronic
patient records (14; 25%), asking the patient verbally
(11; 20%), forms sent by fax (6; 11%), visually through
the screen (5; 9%) or received via email (2; 3%). For 22
patients (39%), the specialists did not have access to all
the clinical data they needed, and in 12 cases (21%) they
needed to perform a physical examination that was not
possible via video consultation.
Specialists’ opinions
The specialists believed that the necessary physical exam-
ination could be performed adequately by a GP or a
trained nurse in 100% and 96% of the cases, respectively.
Nevertheless, they stated that they could have made a
Table 1. Patient characteristics.
Number (%)
Gender
Male 31 (55)
Female 25 (45)
Distance to the state’s capital city (km)
200–1000 16 (29)
More than 1000 40 (71)
Type of diabetes
Type 1 18 (32)
Type 2 37 (66)
Other type 1 (2)
Treatment
Insulin 44 (79)
Other hypoglycaemic agents 12 (21)
Complications*
Neuropathy 7 (12)
Nephropathy 15 (27)
Ischaemic heart disease 6 (11)
Retinopathy 4 (7)
Diabetic foot 3 (5)
Other complications 2 (4)
None 27 (48)
*the percentages do not add up to 100% because of cases with more than
one complication.
Table 2. Changes in management of the patients’ medications (changes made in 35 of the 56 consultations). Values shown are numbers (%).
Initiation of a medication Adjustment of dose Change of regimen Cessation of a medication
Insulin 2 (4) 22 (39) 1 (2) 3 (5)
Oral hypoglycaemic agents 2 (4) 6 (11) 1 (2) 1 (2)
Hypotensive agents 1 (2) 0 1 (2) 0
Anti-lipid agents 2 (4) 1 (2) 0 0
Other medications 1 (2) 2 (4) 1 (2) 0
Table 3. Recommendations apart from medication change.
Number (%)*
Order laboratory tests 42 (75)
Refer to an allied health professional 7 (12)
Refer to another specialist 4 (7)
Order other diagnostic tests 2 (4)
Arrange hospital admission 1 (2)
General advice 7 (12)
Other recommendations 7 (12)
*the percentages do not add up to 100% because of cases with multiple
recommendations.
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better decision in 19 consultations (34%) if it had been an
in-person encounter. No significant difference was found
between the specialists’ opinion on the possibility of
making better decision and the baseline characteristics of
the patients (i.e. age, gender, type of diabetes, treatment
plan or having diabetes complications).
Discussion
The present study showed that in a high proportion of
cases the specialist endocrinologists were confident with
their recommendations for patients with diabetes made
via videoconferencing. The inability to perform a physical
examination was not a limiting factor. The specialists
thought that the discussion with the patient, in addition
to access to clinical data, was adequate for conducting a
consultation remotely. Also, the specialists believed that
GPs and nurses could safely perform any required phys-
ical examination on behalf of the specialists.
All of the recommendations made for the management
of diabetes could be enacted remotely. Although the spe-
cialists thought that in 34% of the consultations they
could make a better decision if the consultation was in-
person, they actually needed to see the patient in-person
only in 5% of the cases. This decision could be regarded as
a trade-off between the quality of care, and the cost or
inconvenience of taking a long trip by the patients to
attend a conventional specialist clinic. Long distances
between patients and major hospitals can make telemedi-
cine the only choice for patients who otherwise would not
have access to specialist care. The present findings com-
plement those from a previous study which analysed the
process of conventional diabetes consultation.7 The pro-
cess analysis of in-person diabetes consultations showed
no change in medication of the patients in 32% of the
cases, which is similar to the value in the present study
(37%).
It appears that no single patient characteristic is a sig-
nificant predictor of the suitability of telemedicine for out-
patient diabetes consultations. The results of the present
study support the alternative model suggested by Toledo
et al.8 to increase access to specialist care for people with
diabetes who are living in remote and rural areas. An ini-
tial video consultation is an acceptable alternative to an
in-person interaction. If a physical examination is con-
sidered necessary, the specialist can either arrange a
follow-up consultation in person, or arrange for a local
practitioner to perform the requisite examination.
Although videoconferencing is often used in the clinical
management of diabetes, there are few published reports
of such activities. Most publications on telemedicine for
diabetes report patient education, remote monitoring and
improving self-management.
The present study had certain limitations that might
reduce the generalizability of the results. The data net-
work used was highly reliable but similar networks may
not be available in all countries. Also the study design did
not allow us to identify any potential cases in which the
management of patients was suboptimum. Studies with
more rigorous design, such as reliability studies or clinical
trials comparing telemedicine with in-person consult-
ations, are needed to assess the safety of clinical manage-
ment of diabetes via telemedicine.
Conclusion
Process analysis of video consultations of people with dia-
betes showed that most of the elements of specialty con-
sultation could be performed remotely. The inability to
examine the patient physically does not seem to be a limit-
ing factor. Video consultation can substitute for a large
proportion of in-person specialist consultations for people
with diabetes who are referred to endocrinology
specialists.
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8. PATIENT SATISFACTION WITH VIDEO CONSULTATION FOR 
DIABETES 
8.1. Paper Information 
Patient satisfaction is important in successful implementation of telemedicine services. Most 
of published papers on satisfaction with telemedicine were part of exploratory, 
demonstration, or feasibility studies, and very few studies have reported the satisfaction for 
patients with a routine telemedicine service. Nevertheless, no instrument was found in the 
literature specifically designed for assessing the patient satisfaction with videoconferencing. 
The aim of this study was to develop a questionnaire for assessing patient satisfaction with 
video tele-consultations and preliminarily evaluate it in a routine tele-endocrinology clinic. 
The following paper has been published in Diabetes Technology & Therapeutics (2015), 
Volume 17, Issue 1, [Epub ahead of print]. The candidate, Farhad Fatehi, was primarily 
responsible for conducting the research and writing the manuscript. The paper's co-author, 
Melinda Martin-Khan, Anthony C Smith, Anthony W. Russell and Leonard C Gray, 
contributed to this paper in various aspects as listed in the preliminary pages of this thesis. 
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ORIGINAL ARTICLE
Patient Satisfaction with Video Teleconsultation
in a Virtual Diabetes Outreach Clinic
Farhad Fatehi, MD, MSc,1,2 Melinda Martin-Khan, PhD,3 Anthony C. Smith, PhD,1
Anthony W. Russell, MD, PhD,4,5 and Leonard C. Gray, MD, PhD1,3
Abstract
Objective: This study assessed the level of patient satisfaction with diabetes remote consultations via video-
conferencing in a virtual outreach clinic.
Materials and Methods: A cross-sectional observational survey was conducted of people with diabetes who
were living in regional cities of Queensland, Australia, and remotely consulted by endocrinologists at the
Princess Alexandra Hospital tele-endocrinology clinic in Brisbane during autumn 2013. A questionnaire with 15
multiple-choice questions and one open-ended question was developed for assessing patient satisfaction with
videoconferencing for specialty consultation. The questionnaire items showed strong internal consistency
(Cronbach’s a= 0.90). Patient satisfaction was assessed by this 16-item questionnaire exploring four dimen-
sions: equipment/technical issues; communication and rapport; clinical assessment; and program evaluation.
Results: In total, 62 questionnaires were mailed to the patients, with 24 (39%) surveys completed and returned.
The quality of video had the highest satisfaction rate (100%). The lowest satisfaction scores were reported in the
‘‘Clinical Assessment’’ dimension, in which 21% of respondents (five of 24) were concerned that the lack of
physical contact could be a problem for managing their diabetes. The patients did not report any problem with
building rapport with their consultant over the videoconference.
Conclusions: The patients with diabetes who were seen remotely by endocrinologists via videoconferencing
were generally satisfied with remote consultation. The questionnaire developed specifically for diabetes video
teleconsultation in this study is useful for the measurement of patient satisfaction, and a modified version may
be used in other clinical specialties.
Introduction
Satisfaction is an important quality indicator ofhealthcare services.1 It is a complex concept and multi-
dimensional construct that is affected by many parameters.2
Several definitions have been proposed for satisfaction, but
no consensus has been reached.3 Although some authors have
provided complex psychological models and relate it to hu-
man cognition, in most studies satisfaction is regarded as a
match between a patient’s expectations and the services that
he or she receives.4 Thus, dissatisfaction occurs when pa-
tients do not receive the healthcare service they were ex-
pecting (i.e., a marked mismatch between expectations and
experience). Although the importance of qualitative methods
such as observation, in-depth interviews, and focus group
discussion has been increasingly acknowledged, most satis-
faction studies still use quantitative methods that rely on
administering a questionnaire. Patient satisfaction question-
naires traditionally use measures such as Likert scales,
Guttman scales, or semantic differential scales.5
In the field of telemedicine, researchers have emphasized
that successful implementation and adoption of telemedicine
services depend on acceptance and satisfaction of both
healthcare consumers and service providers.6 Despite numer-
ous publications on patient satisfactionwith telemedicine,7–10 it
has been identified that this aspect of telemedicine needs further
investigation.11,12 The published works on telemedicine satis-
faction tend to rely on a general assumption that both patient
and provider levels of satisfaction with telemedicine are high.
Thus further research on patient satisfaction has been a lower
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priority compared with other domains of telemedicine research
such as effectiveness, reliability, or economic benefit. How-
ever, there are several insufficiencies associated with satisfac-
tion studies that limit the generalizability of the findings.11 In
addition to general shortcomings of satisfaction studies such as
inability to identify the concept and ambiguity in the definition
of outcome measures, most of the telemedicine satisfaction
studies have been part of exploratory, demonstration, or fea-
sibility studies, rather than surveying a well-established and
operational telemedicine service. Furthermore, the patient se-
lection criteria and refusal rate have not been clearly stated in
most studies. This suggests the possibility of selection bias in
favor of higher levels of satisfaction.13
In a systematic review of literature, Mair and Whitten11
analyzed the quality of the satisfaction studies of real-time
telemedicine services and more specifically video consulta-
tion for publications from 1989 to 1998. They highlighted
several limitations with the published work. Only a few
studies defined satisfaction, and of those that did, all used
different definitions. Therefore it was not possible to discern
from the studies which satisfaction parameters they have
evaluated. The settings of the studies were also quite het-
erogeneous. For instance, one of the largest U.S. studies in
this field was conducted in a prison setting, which is quite
different from the usual clinical environment.14
Because telemedicine research involves the use of a range
of modalities and communication technologies, it is chal-
lenging to find a universal set of questions that apply to all
telemedicine solutions. For example, a questionnaire devel-
oped for a store-and-forward telemedicine project is not
suitable for interactive video consultations, and vice versa.
As videoconferencing is gaining more popularity for both
patient education and remote consultation, there is a need for
the development of a reliable and validated instrument for
assessing the level of satisfaction with the services that are
delivered remotely via videoconference. The aim of this
study was to evaluate patient satisfaction with interactive
video teleconsultation in a virtual diabetes outreach clinic.
Materials and Methods
Settings of the virtual outreach clinic
The Princess Alexandra Hospital (PAH) is a tertiary
teaching hospital in Brisbane, QLD, Australia. It operates a
wide range of conventional outpatient clinics, including
diabetes and endocrinology. Recently, the PAH Telehealth
Centre was established to enhance the capacity of several
traditional outreach clinics serving rural areas of Queens-
land by means of interactive videoconferencing. Specialist
doctors from several clinical disciplines, including diabetes
and endocrinology, as well as cardiology, orthopedics,
geriatrics, and dermatology, provide teleconsultations via
videoconferencing to those patients referred by their gen-
eral practitioner (GP) for specialty consultation. The de-
tails of the telemedicine service for diabetes patients and
analysis of the process of care provided remotely to them
have been published elsewhere.15 The service delivery
conforms to the hub-and-spoke model,16 in which all the
administration and coordination tasks are carried out cen-
trally from the PAH (the hub). The distance of remote sites
(the spokes) from the hub varies from 220 km to 1,700 km
(Fig. 1).
The patients who are living elsewhere need to travel to the
nearest health center (spoke) to access a videoconferencing
system for their teleconsultation with a specialist based in
Brisbane. The videoconferencing is achieved using the
Queensland Health Wide Area Network, which is a high-
speed network that connects to all Queensland Health end
points across the state. Both local and remote sites are
equipped with dedicated videoconferencing units, including
TV screen, commercial grade codec, pan-tilt-zoom camera,
and microphone. The general connection speed (technically
referred to as bandwidth) ranges from 512 kbits/s to 2.3
Mbits/s, depending on the site-specific connections. The vid-
eo consultation is hosted by a local clinician (doctor, nurse,
or allied health professional) when available. In some cases,
the patient may be accompanied by a friend or family
member during the videoconference.
Development of the questionnaire
No validated questionnaire was found in the published
literature for assessing satisfaction of patients with video
teleconsultation. The main domains of satisfaction with real-
time telemedicine were identified through review of the lit-
erature, and a set of questions was accumulated from three
relevant studies.17–19 After duplicate and similar items were
FIG. 1. The locations of cities where the diabetes remote
consultation was delivered, with their distance to Brisbane,
the capital city of Queensland. Color images available on-
line at www.liebertpub.com/dia
2 FATEHI ET AL.
56
removed, 16 questions were selected by a panel of experts.
The panel comprised two specialist doctors (one endocri-
nologist and one geriatrician) with at least 5 years of video
teleconsultation experience and two senior researchers with
more than 9 years of research in the field of telemedicine.
A questionnaire with 15 multiple-choice questions and one
open-ended question was developed to assess satisfaction of
diabetes patients who have had an appointment with their
endocrinologist via videoconference. The multiple-choice
questions scored on a 5-point Likert-type scale (from 1 for
strongly disagree to 5 for strongly agree). These questions
covered four domains of satisfaction with the video consulta-
tion: equipment and technical issues (three questions); com-
munication and rapport (three questions); clinical assessment
(four questions); and overall evaluation of the program (five
questions). The open-ended free-text question enabled the
participants to comment on their experience with the video
consultation and express their opinion in this regard (Table 1).
The questionnaire had a scoring range of 15–75. A score of
15 indicates all responses as ‘‘strongly disagree,’’ and a score
of 75 means all responses were ‘‘strongly agree.’’ Higher
scores favor video consultation, and lower scores favor
conventional face-to-face consultations. The overall internal
consistency (Cronbach’s a) of the questions was 0.90, which
indicates a strong correlation between the 15 items of the
questionnaire. It was 0.80 for the equipment/technical issues,
0.64 for the communication/rapport, 0.82 for medical con-
cerns, and 0.85 for the program evaluation (Table 2). For new
questionnaires, an internal consistency of more than 0.7 is
regarded as acceptable.20
Participants
Those people with diabetes who had a video consultation
with specialists at the PAH Telehealth Centre betweenMarch
and May 2013 were included in the study. The questionnaire
was mailed to the patients’ postal address along with a pre-
paid self-addressed envelope for returning the completed
questionnaire. The questionnaire was anonymous. It was
decided that the completed questionnaire would be returned
to the research team (not the healthcare providers), to mini-
mize the potential for biased responses. The study protocol
was approved by the appropriate institutional ethics com-
mittee (reference number HREC/12/QPAH/479). Participa-
tion in the study was voluntary, and completing the survey
implied a participant’s consent.
Statistical analyses
Reliability of the instrument was measured by internal
consistency among all questions as well as within each of the
four subgroups. Internal consistency was evaluated by
Cronbach’s a. No attempt was made to assess the repeat-
ability of the instrument. As the survey was completed
anonymously, it was not possible to report demographic in-
formation or compare information between respondents and
nonrespondents.
Results
Patients’ satisfaction with video teleconsultation
In total, 62 questionnaires were sent via mail to patients
who had video consultations with a specialist at the PAH
Telehealth Centre, and 24 completed questionnaires were
returned. We were not able to check what proportion of
questionnaires was delivered to the intended persons and how
many were sent back to the researchers. There are anecdotes
on instances of failure of postal delivery services in rural
areas in which the subjects of this survey resided.
Table 1. The Questionnaire for Assessing Patient Satisfaction with Video Teleconsultation
Domain Item number Question
Equipment/technical issues 1 I was satisfied with the quality of the picture (video) during the
videoconference.
2 I was satisfied with the quality of the sound (audio) during the
videoconference.
3 I experienced NO technical difficulties during the videoconference
(e.g. unexpected disconnections, loss of sound or picture, etc.).
Communication and rapport 4 The videoconference did not make me feel nervous and uncomfortable.
5 I could easily explain my medical problems to the doctor in the video visit.
6 I took my doctor’s advice given by video seriously.
Clinical assessment 7 I was confident that the clinician could assess my condition via
videoconferencing as if I was there.
8 I believe the doctor understood my blood sugar situation during the video visit.
9 I was confident that the doctor could evaluate my medication requirements
(insulin or tablets) via video visit.
10 The lack of physical contact in a video visit is NOT a problem for managing
diabetes.
Program evaluation 11 Telehealth enables me to save money and time.
12 Telehealth improves my access to specialist care.
13 I would like to use telehealth again in the future.
14 I believe that a video visit is good for achieving good control of my diabetes.
15 I prefer to have my next consultation via video visit.
Comments 16 If you have any comments or suggestions about the telehealth service please
note here.
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Patients’ responses to the questionnaire on satisfaction
with videoconferencing are summarized in Table 3. On
average, more than 22 of the 24 respondents were satisfied/
highly satisfied with the equipment and technical features of
the videoconference appointment. Also, almost all (23 of
24) of the patients were satisfied with their communication
with the specialist via videoconference. The primary focus
of dissatisfaction for patients was the perception of the
clinical assessment through video consultation. Five re-
spondents reported that the lack of physical contact could be
a problem for managing diabetes. Almost all the partici-
pants (23 of 24) reported that telemedicine had improved
their access to specialist care and would like to use the
service again.
Table 2. Analysis of the Questionnaire Items for Cronbach’s a
Item number
Mean of total
score if deleted
Variance of total
score if deleted
Corrected item-total
correlation
Cronbach’s a
if deleted
1 60.4 49.6 0.30 0.90
2 60.6 44.8 0.62 0.89
3 60.6 47.7 0.41 0.90
4 60.6 48.6 0.41 0.90
5 60.7 46.7 0.62 0.90
6 60.5 48.0 0.49 0.90
7 61.0 43.4 0.68 0.89
8 60.8 45.2 0.61 0.89
9 60.8 42.8 0.76 0.89
10 61.4 40.8 0.60 0.90
11 60.5 46.0 0.49 0.90
12 60.6 45.4 0.77 0.89
13 60.6 45.1 0.80 0.89
14 60.1 43.6 0.73 0.89
15 61.0 44.2 0.66 0.89
Table 3. Survey Results
Question
Strongly
disagree Disagree Neutral Agree
Strongly
agree
Equipment/technical issues
I was satisfied with the quality of the picture (video) during the
videoconference.
8 16
I was satisfied with the quality of the sound (audio) during the
videoconference.
1 1 7 15
I experienced NO technical difficulties during the videoconference
(e.g., unexpected disconnections, loss of sound or picture, etc.).
2 8 14
Communication and rapport
The videoconference did not make me feel nervous and uncomfortable. 12 12
I could easily explain my medical problems to the doctor in the video
visit.
1 14 9
I took my doctor’s advice given by video seriously. 11 13
Clinical assessment
I was confident that the clinician could assess my condition via
videoconferencing as if I was there.
2 1 13 8
I believe the doctor understood my blood sugar situation during the video
visit.
1 1 13 9
I was confident that the doctor could evaluate my medication
requirements (insulin or tablets) via video visit.
2 13 9
The lack of physical contact in a video visit is NOT a problem for
managing diabetes.
1 4 4 7 8
Program evaluation
Telehealth enables me to save money and time. 1 1 6 16
Telehealth improves my access to specialist care. 1 11 12
I would like to use telehealth again in the future. 1 10 13
I believe that a video visit is good for achieving good control of my
diabetes.
1 3 12 8
I prefer to have my next consultation via video visit. 1 3 12 8
Data are the number of responses in each category.
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Patients’ comments on the remote consultation service
One-third (eight of 24) of the respondents provided com-
ments in the open-ended question regarding their opinion and
experience of remote consultation via videoconferencing.
Five patients expressed their appreciation and satisfaction
with the service, mostly because of avoidance of travel and
saving money. One respondent was concerned that the strict
scheduling of telehealth appointments could introduce the
feeling of being rushed in order to keep to schedule. One
respondent expressed unhappiness with the nurse who hosted
the remote consultation, and finally one respondent expressed
his or her preference for in-person consultation rather than
video teleconsultation.
Discussion
Telemedicine differs from conventional face-to-face en-
counters in several ways that may adversely affect the doc-
tor–patient relationship. Inability to perform a physical
examination and decreased nonverbal communication are
among the most important concerns in remote consulta-
tions.21 These characteristics may contribute to patient dis-
satisfaction. However, a recent comprehensive literature
review shows that videoconferencing has been used for
remote consultation of patients in a range of medical disci-
plines, including the ones that may rely more on physical
examination, such as neurology.22 Previous studies have
evaluated the level of satisfaction with telemedicine services
from various perspectives, but no validated questionnaire
was found in the literature specifically designed for video
teleconsultation. In this study, we developed a patient satis-
faction questionnaire and evaluated the level of diabetes
patient satisfaction with remote video consultations.
Our survey showed that some patients were concerned
with the lack of physical contact in remote consultation via
videoconferencing. This may reflect concern about the long-
term complications of diabetes such as foot ulcers or diabetic
retinopathy. In circumstances when this is an issue, the en-
docrinologist would work in partnership with the patient’s
GP or nurse practitioner, to observe the physical examination
being completed if the GP or nurse was in attendance with the
patient for the videoconference or to ask for a physical ex-
amination to be completed by the GP at the patient’s next
clinical visit. Previous research shows, from an endocrinol-
ogist’s perspective, that a GP or a trained nurse can perform
the physical examination needed for a diabetes specialist
consultation.23 Despite this issue, the overall proportion of
patients with such concerns (five of 24) was relatively low.
This supports the findings of other studies on patient satis-
faction with telemedicine.17 Most of the patients (22 of 24)
reported their confidence with the clinical assessment of the
doctor of their health condition and medication requirement.
All of the respondents in this survey were satisfied with the
quality of video during the consultation. One respondent re-
ported dissatisfaction with the audio transmission. None of
the respondents indicated any technical difficulty with the
videoconferencing. This level of satisfaction with technical
aspects of telemedicine is mainly due to highly reliable in-
frastructure and networking available in the Queensland
public hospitals, clinics, and health centers throughout the
state. Similar reliable networks and telehealth infrastructure
may not be available in other countries.
The comment from one of the respondents on the attitude
of the nurse who hosted the remote consultation at the remote
side and the responses to the questionnaire shows that he or
she has differentiated the level of satisfaction with the vehicle
of healthcare delivery from the people who are providing the
service, but it could be not true for some people. In order to
isolate these two determinants of the healthcare quality
(personnel and modality), future studies on development of
satisfaction assessment instrument may consider inclusion of
a separate set of questions to evaluate the performance of the
personnel while asking for the satisfaction with the modality
(e.g. videoconferencing).
All the administrative tasks and coordination functions of
telemedicine sessions were conducted centrally by the
personnel of the PAH Telehealth Centre, which eliminated
the burden of those issues from the people on the patient’s
side. Also, as the patients were attending their local clinic or
health center for the videoconference, they did not have to
know how to operate the telemedicine equipment; this issue
should be specifically considered when evaluating home
telecare services in which the remote device needs to be
operated by the patients themselves, caregivers, and/or
family members.
This study has several limitations. The number of subjects
participating in this study and the response rate were not high,
and diabetes was the only health condition investigated. Pro-
vision of remote consultations for other diseases may need
different requirements in terms of physical examination (e.g.,
for orthopedics) or audio/video quality (e.g., for dermatology)
that should be considered in developing a comprehensive in-
strument. Also, the setting of our study (videoconferencing
between a hospital and a rural clinic) limits the generalizability
of the results, so that for other situations such as home telecare
in which the patients need to operate the telemedicine device
by themselves, additional sets of questions should be added to
the questionnaire. The questionnaire introduced in this study
may be regarded as a preliminary version of an instrument for
assessing the satisfaction of patients with remote consultation
using videoconferencing. Although the questions have been
formulated in the context of diabetes, the specific scripting
could be modified to suit other health conditions. Further re-
search is required to confirm the validity of the questionnaire
introduced in this article.
Conclusions
The survey demonstrated that patients who had an ap-
pointment with their specialist via videoconferencing were
generally satisfied with the service provided. This prelimi-
nary evidence shows that the questionnaire developed in this
study is useful for the measurement of diabetes patients’
satisfaction with interactive video teleconsultation and could
be modified for use in other clinical specialties.
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9. METHODOLOGY OF A CLINICAL TRIAL FOR EVALUATING THE 
RELIABILITY OF VIDEOCONFERENCING FOR REMOTE 
CONSULTATION OF DIABETES 
9.1. Paper information 
 
Telemedicine applications are increasingly implemented by service providers to link patients 
with doctors, or doctors to specialists. The reduction in equipment costs makes video 
consultation a viable alternative to travel. The escalating adoption of video consultation as a 
vehicle for medical service makes it challenging for research on the reliability of the use of 
video conferencing to keep pace.  
The aim of this paper was to describe the design of a randomised controlled trial to identify 
the reliability of videoconferencing for specialty consultation for people with diabetes. This 
protocol follows the methodology of non-inferiority trials that is recommended for assessing 
new health care interventions.   
This research design involves paired consultations in two study groups.  One group compares 
the level of agreement between outcomes of consultations provided via videoconference with 
those of face-to-face.  As this is a challenging group, with no previous indication of 
agreement between endocrinologists on the outcome of diabetes consultation in usual 
practice, an additional group (standard clinical practice) includes paired face-to-face 
consultations.  The level of agreement in the videoconference group can then be considered 
by comparing agreement in the standard clinical practice group. 
The following paper has been published (online ahead of print) in the BMC Medical 
Informatics and Decision Making journal (2014; doi: 10.1186/1472-6947-14-11). The 
candidate, Farhad Fatehi was primarily responsible for conducting the research and writing 
the manuscript. The paper's co-authors, Melinda Martin-Khan, Leonard C Gray, and Anthony 
W Russell contributed to this paper in various aspects as listed in the preliminary pages of 
this thesis. 
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Design of a randomized, non-inferiority trial to
evaluate the reliability of videoconferencing for
remote consultation of diabetes
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Abstract
Background: An estimated 366 million people are living with diabetes worldwide and it is predicted that its
prevalence will increase to 552 million by 2030. Management of this disease and its complications is a challenge for
many countries. Optimal glycaemic control is necessary to minimize complications, but less than 70% of diabetic
patients achieve target levels of blood glucose, partly due to poor access to qualified health care providers.
Telemedicine has the potential to improve access to health care, especially for rural and remote residents. Video
teleconsultation, a real-time (or synchronous) mode of telemedicine, is gaining more popularity around the world
through recent improvements in digital telecommunications. If video consultation is to be offered as an alternative
to face-to-face consultation in diabetes assessment and management, then it is important to demonstrate that this
can be achieved without loss of clinical fidelity. This paper describes the protocol of a randomised controlled trail
for assessing the reliability of remote video consultation for people with diabetes.
Methods/Design: A total of 160 people with diabetes will be randomised into either a Telemedicine or a
Reference group. Participants in the Reference group will receive two sequential face-to-face consultations whereas
in the Telemedicine group one consultation will be conducted face-to-face and the other via videoconference. The
primary outcome measure will be a change in the patient’s medication. Secondary outcome measures will be
findings in physical examination, detecting complications, and patient satisfaction. A difference of less than 20% in
the aggregated level of agreement between the two study groups will be used to identify if videoconference is
non-inferior to traditional mode of clinical care (face-to-face).
Discussion: Despite rapid growth in application of telemedicine in a variety of medical specialities, little is known
about the reliability of videoconferencing for remote consultation of people with diabetes. Results of this proposed
study will provide evidence of the reliability of specialist consultation offered by videoconference for people with
diabetes.
Trial registration number: Australian New Zealand Clinical Trials Registry ACTRN12612000315819.
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Background
Diabetes Mellitus (DM) is a common disease with in-
creasing prevalence in many countries. More than 366
million people are estimated to have diabetes worldwide
and it is projected to increase to 552 million by 2030, af-
fecting 9.9% of the global adult population [1]. Managing
diabetes and its complications is very costly, and creates
a substantial burden on the health care economy. There
is no cure; instead optimal glycaemic control is required
to minimize complications [2]. However, less than 70%
of people with diabetes are achieving target glycaemic
control, demonstrating that effective disease manage-
ment for people with diabetes remains a challenge [3,4].
For some patients, particularly in rural areas, not achiev-
ing target glycaemic controls is at least in part due to
poor access to qualified health care providers [5,6]. In
response to the growing demand for health care and a
decreasing availability of health care providers, informa-
tion and communications technology (ICT) has shown
potential to improve the accessibility of health care ser-
vices and to reduce costs of health care delivery [7].
Telemedicine is the provision of medical and health ser-
vices remotely using information and communication
technology [8]. The telemedicine interactions are generally
divided into two categories: synchronous (occurring in real
time such as videoconferencing) and asynchronous (store-
and-forward solutions such as transmission of a blood glu-
cose level from a glucometer to a health centre).
Asynchronous (store-and-forward) telemedicine has
been successfully implemented in the medical specialities
such as pathology [9], radiology [10] and dermatology [11]
where real time exchange of information between health
care providers and consumers is not essential. In contrast,
synchronous telemedicine requires both parties to interact
with each other in real time using communication technol-
ogy. Among the synchronous telemedicine solutions,
videoconferencing – real time exchange of voice and
image - is becoming popular through rapid achievements
in digital communication technology. Video teleconsulta-
tion has been used in a wide range of disciplines from
emergency medicine [12] to mental health [13], but it has
been emphasized that most existing disciple-specific studies
cannot be generalized to other tele-medical contexts [14].
In a systematic review on synchronous and asynchronous
teleconsultation for diabetes care, Verhoeven et al. sug-
gested that both teleconsultation solutions are feasible,
cost-effective and reliable for delivering diabetes care. How-
ever they identified a lack of high quality studies and diver-
sity in the included studies [15]. Several studies have
reported results of using videoconferencing for diabetes
care. However, almost all used videoconferencing for be-
havioural therapy including diabetes education, self-
management training, nutrition counselling, and collabora-
tive goal setting [16]. The accuracy of videoconferencing
for specialist telediagnosis and assessment of selected dis-
eases has been studied (e.g., Alzheimer’s disease) [17], but
there is no published study on the reliability and accuracy
of videoconferencing for clinical consultation with regard
to medical specialist evaluation and management of dia-
betic patients.
If a doctor is able to assess and manage a diabetic patient
via videoconference with a similar level of reliability as a
face-to-face consultation, the medical profession could have
confidence in including video consultation as a regular as-
pect of their clinical care. A clinician who regularly sees pa-
tients for evaluation of their diabetic management may
choose to substitute some of the regular face-to-face con-
sultations with a video consultation. This has important
implications for patients isolated by either their physical lo-
cation (e.g., rural communities) or their function (e.g., dis-
abled older people in aged care facilities) and paves the way
for at least some specialist consultation for people living in
rural or remote areas to avoid the expense and inconveni-
ence of long distance travel. It may also increase the oppor-
tunities for some people to receive advice in situations
where they previously may have not, due to an inability to
travel. This protocol describes a research project that will
evaluate the reliability of clinical decisions made during a
diabetic patient consultation via videoconference.
Typically the aim of a Randomized Controlled Trial
(RCT) is to identify if superiority exists between two or
more parallel groups to guide decision making, for example
whether to replace a current medication or procedure with
a new one. However, an alternative analytical approach is
required when the aim is to identify if an innovation is suit-
able to replace an existing process at the same level of
efficacy [18]. Such methodology is referred to as a non-
inferiority trial. A priori defined level of clinically acceptable
variation between the two modes of delivery is used to de-
termine the outcome. This study is a non-inferiority trial
comparing the clinical outcomes of video consultations
against those of conventional face-to-face consultations.
Aims and objectives
In this study we are seeking to identify if telemedicine is
a reliable vehicle for providing specialty consultation for
people with diabetes using videoconferencing, with the
implication that it would be useful to utilise when usual
care is either not available or difficult to deliver. The
aim of the study is to test the level of clinical agreement
achieved using specialist to patient videoconferencing
(VC) compared with face-to-face (FTF) consultation. To
place this level of agreement in context, it will also es-
tablish the level of agreement among specialists using
face-to-face consultation. This approach enables the
variation in clinical decision making among clinicians to
be identified, and thus to be differentiated from the ef-
fect of the VC mode of service delivery.
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This study will test the hypothesis that the clinical assess-
ment and recommendations as determined by an alteration
in medication type or dose made by endocrinologists for
people with diabetes via videoconference are significantly
different from those made through face-to-face consult-
ation (null hypothesis). Secondary hypotheses will apply the
same analytic techniques to the other aspects of diabetes
consultation: (i) ordering lab tests or other diagnostic inter-
vention; (ii) initiation of new medication(s) or dose adjust-
ment of the previously prescribed drugs for dyslipidaemia
and/or hypertension; (iii) detection or management of dia-
betes related complications; and (iv) referring to other spe-
cialists or arranging hospital admission.
Methods/design
This study is a repeated-measure non-inferiority random-
ized controlled trial. All patients participating in the study
will receive two consultations (one original consultation
and one additional consultation; called paired-consultation
in this paper) by two different endocrinologists. Level of
agreement between the recommendations made viaVC ver-
sus FTF for the same patient by two endocrinologists will be
calculated. This constitutes VC-FTF paired-consultations.
Since there is likely to be a certain level of clinical variability
between clinicians, the level of agreement in VC-FTF
paired-consultations will then be compared against the level
of agreement between two endocrinologists when they con-
sult a patient in standard clinical practice (FTF-FTF). This
arrangement will determine whether any lack of agreement
is likely to be a result of the videoconference modality, or
just normal variation between doctors.
Study setting and participants
This study will be conducted in the outpatient diabetes
clinic of the Princess Alexandra Hospital (PAH) which is a
tertiary teaching hospital in Brisbane, Australia. People
with diabetes who have an appointment with an endocrin-
ologist as a new or review case for the purpose of improv-
ing management of their diabetic condition will be
approached and invited for participation. Six endocrinolo-
gists who attend the clinic routinely will visit the patients
as scheduled (these are referred to as ‘routine endocrinolo-
gists’ in this paper). Another endocrinologist (referred to
as the ‘research endocrinologist’ in this paper) will be
employed for the purpose of this research to undertake
the additional consultation for each patient who consents
to participate in the trial. The additional consultation will
be conducted by the research endocrinologist prior to the
original consultation for each patient. However, the par-
ticipant patients will receive both their consultations on
the same day in the same clinic session. The routine and
research endocrinologists are all specialist doctors with
the same qualifications and credentials (i.e. accredited by
the Royal Australian College of Physicians).
Inclusion and exclusion criteria
Eligible participants include patients (i) with a confirmed
diagnosis of diabetes, (ii) who are 18 years of age or
older. Patients will be excluded if (i) they are severely ill,
(ii) unable to communicate effectively (blind, deaf, mute,
etc.), or (iii) speak in a language other than English if an
interpreter is not available.
Randomisation
Participants will be randomly allocated in a 1:1 ratio into
one of two study groups (Telemedicine or Reference
group). In the Telemedicine group the participants will
receive a paired-consultation in which one of the consul-
tations is via video (FTF-VC or VC-FTF), but in the Ref-
erence group both consultations will be face-to-face
(FTF-FTF). Figure 1 outlines the randomisation and
allocation process. The first consultation in each paired-
consultation will be provided by the research endocrin-
ologist, whereas the second consultation will be provided
by one of the routine endocrinologists of the clinic.
Since the order of VC vs. FTF consultations are also ran-
domised, there will be three potential configurations for
the paired consultations of each participant (Table 1).
With such design, half of the video consultations will be
conducted by the research endocrinologist, and the
other half by the routine endocrinologists of the clinic.
A block randomisation with the block size of eight
will be used to ensure balanced representation of the
participants in each group. The randomised configur-
ation will be provided by an independent biostatistician
using SAS software. Opaque sealed envelopes with se-
quential numbers will be used for allocating the partici-
pants into the groups.
Informed consent and recruitment
Eligible patients will be contacted by phone prior to
their appointment to explain the project and seek verbal
consent. Once checked-in to the clinic for their appoint-
ment, patients who have verbally consented will be given
the participant information sheet, and written consent
will be obtained. Each participant will be offered two
movie vouchers (valued roughly US$ 30.00) as a com-
pensation and appreciation for participating in this
study. Non-consenting or excluded patients will receive
their routine service at the clinic.
Usual care
Princess Alexandra Hospital operates three diabetes clinics
a week in the outpatient clinic building. New patients are
allocated a 45-minute, and review patients usually a 30-
minute time slot for consultation. Wherever possible,
review patients are scheduled to see the same endocrin-
ologist they saw for their previous appointment to ensure
continuity of care.
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Following arrival at the clinic, the patient is received
by a diabetes nurse practitioner and initial assessments
such as measuring weight and blood pressure are per-
formed. The nurse also downloads the blood glucose
readings from the patient’s glucometer and updates the
patient charts with the latest lab results. The patient
then visits the endocrinologist. At the conclusion of the
consultation, the doctor writes the progress notes and
any pharmacy scripts that are required, requests path-
ology test(s), refers the patient to another specialist or
other health professional where indicated, or arranges
for hospital admission if needed. The patient is then
scheduled for another follow up outpatient appointment,
or care is transferred back to the referring GP with a
management plan.
Intervention
All participants, both in the Telemedicine and Refer-
ence groups, will receive an additional consultation
(consultation 1) by the research endocrinologist who is
employed for this study. This endocrinologist is offi-
cially qualified and credentialled to visit and manage
patients at the clinic. The additional consultation will
always occur prior to the original consultation (consult-
ation 2). For the participants in the Reference group,
both consultations will be face-to-face: consultation 1
by the research endocrinologist and consultation 2 by
one of the routine endocrinologists of the clinic. For
the participants in Telemedicine group, one consult-
ation will be face-to-face and the other one via video-
conferencing. The format of the first and second
consultations (FTF-VC, or VC-FTF) for the partici-
pants in this group will be determined in the random-
isation process. The final recommendation for patient
management will be provided by the routine endocri-
nologists at the end of second consultation.
To ensure that the integrity of usual patient care is
maintained for the participants in the Telemedicine
group who will have their second consultation via vid-
eoconferencing (Table 1: configuration 2.2), they will
be able to meet the endocrinologist face-to-face imme-
diately after video-consultation, if required by either
the endocrinologist or the patient.
Figure 1 Flow diagram of randomisation and allocation to paired consultations method.
Table 1 Potential configurations of paired consultations
for randomisation
Group Configuration Consultation 1
(by the research
endocrinologist)
Consultation 2
(by the routine
endocrinologists)
Reference (50%
of participants)
1 FTF FTF
Telemedicine
(50% of
participants)
2.1 VC FTF
2.2 FTF VC
FTF: Face-to-Face, VC: Videoconference.
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Access to patient information in video consultations
To be able to isolate the effect of videoconferencing
from other factors on the outcome of each consultation,
we assume that doctors would have access to the same
patient information as in a face-to-face consultation.
Since the endocrinologist and the patients will be in the
same building for both face-to-face and video consulta-
tions, it will be possible to provide the endocrinologists
with the full records of the patients in hard copy during
the videoconferencing as well as access to the electronic
patient record via the Queensland Health network. Simi-
lar to original consultations, the latest blood glucose
readings will be downloaded from each patient’s gluc-
ometer and entered in the patient record by a practice
nurse upon check-in of each patient to the clinic. That
will ensure that the endocrinologists will have equivalent
access to the latest blood glucose measures, in each of
the paired consultations.
Equipment and connectivity
Remote video consultation will be simulated using one
video-enabled laptop dialling into the diabetes clinic tele-
health studio. The telehealth studio is currently function-
ing and located in the same building of the clinic. For
video consultations, the patient will be accompanied by a
diabetes nurse educator, who will “host” the consultation
and assist with aspects of clinical examination, if needed,
under the direction of the endocrinologist. This arrange-
ment closely emulates the typical situation for diabetes re-
mote consultation by videoconference, where patients are
accompanied either by a nurse or their GP.
The telehealth studio in the diabetes clinic, where the pa-
tient will sit, is equipped with a Tandberg codec 990MXP +
camera unit, Sony Bravia 32” television, and an Audio-
Technica microphone. This codec provides pan, tilt, zoom
functions for the camera by both the local and remote par-
ties. The endocrinologists will use a laptop with 13” screen
and Cisco Telepresence Movi software ver. 4.2 (Cisco sys-
tems, San Jose, California, USA) to connect to the tele-
health studio for conducting the video consultations. Both
Tandberg codec and Cisco Movi are H.264 compliant and
capable of high definition video (up to 1080p 30 fps) encod-
ing and decoding. The laptop has been tested to be com-
patible with the Tandberg codec. This is the configuration
that clinicians use when they provide remote consultations
on a trip or in the facilities that dedicated VC equipment is
not available. The connection will be through the existing
Local Area Network (LAN) and Wireless LAN (WLAN)
within the clinic building. Although the LAN bandwidth is
100 Mbps, the codec and software will be set on 384 Kbps.
This bandwidth is generally regarded as the minimum con-
nection speed for producing acceptable full screen, full mo-
tion video. Although the general connection speeds
between the Queensland Health telehealth centres range
from 512 kbit/s to 2.3 Mbit/s depending on site specific
connections, selection of minimum required bandwidth will
ensure the results of this research to be more generalizable
to the countries that high speed networks are not readily
available.
Outcome measures
The outcome measure of this study is the difference in
level of agreement between the two groups. Agreement will
be calculated for each group (Reference group: FTF-FTF;
Telemedicine group: FTF-VC or VC-FTF) and compared.
For the comparison between two consultations to be ac-
curate, it is necessary that the endocrinologists be blinded
to each other’s assessment and recommendations. Part of
this information can be communicated by the patient,
which is inevitable, however the research endocrinologist
has been requested to refrain from giving information
about the assessment and treatment plan to the patient
during the first consultation. Since the research endocrin-
ologist adds nothing to the patient chart (either in hard
copy or electronic records), it will ensure that the endocri-
nologists will be blinded to each other’s opinion on each
patient.
The primary outcome measure is the level of change in
patient’s medications during the consultation. Based on its
impact, medication change is divided into three categories:
Major, Minor, and No change (Table 2). When more than
one category is applicable to a participant, the highest im-
pact will be regarded as the overall impact of the medica-
tion change.
Secondary outcomes focus on performing the physical
examination, detection of diabetes complications and pa-
tient satisfaction. For each video consultation, the endo-
crinologist will be asked about any technical problem or
Table 2 The categories of the impact of medication
change
Medication Change Category
Insulin Initiation of insulin Major
Cessation of Insulin Major
Change in regimen
(type, injection frequency)
Major
Dose adjustment Minor
No change No change
Other hypoglycaemic agents Initiation of new drugs Major
Cessation of drugs Major
Dose adjustment Minor
No change No change
Other medications
(hypertension, lipids, etc.)
Initiation of new drugs Major
Cessation of drugs Major
Dose adjustment Minor
No change No change
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limitation during the video visit. This will assist in under-
standing the barriers of videoconferencing for consulting
people with diabetes.
Data collection
The endocrinologists will complete a questionnaire for
each patient they consult [see Additional file 1]. The
questionnaire will capture various elements of each con-
sultation and comprises 16 questions in three sections:
(1) Patient characteristics, (2) Procedures and findings,
and (3) Recommendations. The questions have been de-
veloped based on the results of two previous studies: ob-
serving conventional face-to-face diabetes consultations,
[19] and process analysis of video teleconsultation for dia-
betes [20]. The questionnaire has been pilot tested in four
consultations and modifications are made to the questions
as suggested by the endocrinologists and the researchers.
The participants in the telemedicine group will also be
asked to complete a patient questionnaire after their video
consultation. This satisfaction questionnaire comprised 17
questions in five-point Likert-type scale asking for various
aspects of videoconference session.
Statistical methods
Demographic and baseline data will be reported as abso-
lute numbers, percentage, and/or mean +/− SD. Percent-
age agreement and the weighted kappa statistic (Kw) will
be used to assess inter-rater reliability between the two
groups on the agreement on assessments and recom-
mendations made by the endocrinologists [21].
Sample size
This study will evaluate if agreement on the recommen-
dations for the Telemedicine group is not inferior to
agreement in the Reference group by more than an ac-
ceptable amount. This clinically acceptable amount of
variation for diabetes consultation was set as 20% by a
group of expert specialist consultants who had more
than five years of telemedicine experience. The sample
size is calculated based on the incidence rates of 25, 50,
25% for major change, minor change, and no change re-
spectively in the patient medication made by the endo-
crinologists (significance level 5%, power 80%). It will be
possible with a total of 160 participants (80 per each
group) to detect any statistically significant difference for
the true kappa of 0.7 and the null kappa of 0.5.
Ethics and trial registration
Ethics approval for this study has been obtained from
the Human Research Ethics Committee of Queensland
Health (HREC/11/QPAH/645 – 12/03/2012) as well
as The University of Queensland School of Medicine
(2011-SOMILRE-0022 – 4/05/2012). This study is also
registered by Australian New Zealand Clinical Trials
Registry (ANZCTR) as a randomized controlled trial
(ACTRN12612000315819, 20/03/2012).
Discussion
Results of the proposed study will provide an important
and novel insight into provision of clinical consultation
remotely to patients with diabetes by endocrinologists. It
will investigate whether videoconferencing is as reliable
and safe as face-to-face encounter for management of
diabetes. To our best knowledge, this is the first RCT
looking at safety of videoconferencing for specialty con-
sultation of diabetes.
Global prevalence of diabetes has been estimated to in-
crease from 8.3% in 2011 to 9.9% in 2030 among the adult
population [1]. During this period, developing countries will
have a 69% increase in prevalence of diabetes whereas this
increase will be 20% for developed countries [22]. Although
this study has been designed and will be conducted in
Australia which is categorized as a high-income country,
the proposed intervention has potential to be adopted in all
countries that meet the minimum technical requirements
for a videoconferencing with quality accepted for clinical
purposes. The World Health Organization (WHO) has
recommended the incorporation of newer technologies,
such as telecommunications, into the health care system to
improve access to health services in resource limited
countries [23]. Many health centres in low-middle income
countries already have Internet connection that is a pre-
requisite in most of telemedicine interventions including
video teleconsultation, which has been proposed here.
Consultants’ style of clinical practice might be different
from their regular practice while they know they are in-
volved in a research study (Hawthorne effect). However,
this potential effect will equally affect both Reference
and Telemedicine groups. Consultants are also required
to fill in a questionnaire for each consultation in this
study. Items included in the questionnaire that are
derived from observing routine consultations in the
outpatient clinic of a teaching hospital, can act as a
checklist and serve as a decision support system that
possibly improve the process of the consultation, but
again this effect will be equally distributed among the
two groups.
Many hospitals and clinics are currently utilizing elec-
tronic patient records, either as a substitution to the trad-
itional paper-based patient’s records or as a complement
to them. In this study the endocrinologists will have access
to the patient’s complete medical records equally in both
face-to-face and video consultations. This is not the case
in the real world, except for the settings in which the pa-
tient records are fully electronic and accessible via net-
work, and if there is some additional information on hard
copy, that information would be sent to the tele-
consultant before or during the consultation.
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A limitation of the study is the inability to randomise
the order of the endocrinologists that the patient will see
and which endocrinologist would provide the final treat-
ment recommendation. This is not able to be performed
due to practical issues involved around ensuring the
smooth running of a busy outpatient clinic as there is not
time for both endocrinologists to discuss each patient and
provide a collaborative management plan.
Despite the rapid growth in telemedicine services in
Australia and official adoptation of videoconferencing as a
mode of delivery for clinical consultations in Australian
health system and worldwide, little has been published on
safety and reliability of videoconferencing for remote con-
sultation of people with diabetes. This study will fill in the
gap of research in the field of telemedicine for diabetes,
and may serve to guide the application of telemedicine to
the management of other chronic diseases.
Additional file
Additional file 1: Analysis of endocrinology consultation.
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10. RELIABILITY OF VIDEOCONFERENCING FOR REMOTE 
CONSULTATION OF DIABETES: A PILOT RANDOMISED 
CONTROLLED TRIAL 
Based on the findings of the three preliminary studies (Chapters 6-8), a pilot randomised 
controlled trial was designed to evaluate the reliability of videoconferencing for remote 
consultation of people with diabetes who needed to see an endocrinologist in an outpatient 
clinic. This trial was conducted in the outpatient diabetes clinic of a tertiary teaching hospital 
in Brisbane. 75 participants were recruited from October 2012 to July 2013. The participants 
were randomly allocated into the telemedicine group or reference group. Each participant in 
telemedicine group received two consultations: one in-person consultation and one video 
consultation. In the reference group the participants had two in-person (face-to-face) 
consultation. The paired consultations for each participant were provided by two different 
endocrinologists. To evaluate the reliability of the video consultation, the level of agreement 
between endocrinologists in the telemedicine group were calculated by comparing their 
recommendation on the medication changes. In order to be able to assess the impact of 
videoconferencing on the level of agreement between endocrinologists, similar measures 
were also calculated in the reference group where two endocrinologists consulted the 
participants in-person. The findings of this study showed that the level of agreement between 
two endocrinologists on changing anti-diabetes drugs was 64% in the telemedicine group and 
78% in the reference group. Although the level of agreement was lower when one of the 
consultations was via videoconference, the difference was neither statistically, nor clinically 
significant. The level of agreement on changing cardiovascular drugs was 78% in the 
telemedicine group and 76% in the reference group, again not significantly different. 
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10.1. Introduction 
Remote consultations of diabetic patients via videoconferencing could be inferior to the 
conventional face-to-face encounters due to the potential limitations in physical examination 
or access to the patient's data. This pilot randomised controlled study was designed to 
evaluate the reliability of videoconferencing for clinical management of diabetes by 
endocrinologists. We sought to identify the impact of the modality of consultation (i.e. 
videoconferencing versus face-to-face) on the level of agreement between endocrinologists 
when consulting people with diabetes. As doctors do not always agree with each other on the 
management of diseases, we needed to establish the level of agreement between 
endocrinologists when consulting patients in conventional face-to-face encounters, and then 
compare it with that of video consultations. The details of the design of this study were 
described in Chapter 9. 
10.2. Methods 
10.2.1. Participants and setting 
Participants were people with diabetes who had an appointment with an endocrinologist at 
the outpatient diabetes clinic of the Princess Alexandra Hospital in Brisbane, Australia. 
Inclusion criteria were having a confirmed diagnosis of diabetes and age of 18 years or more. 
Exclusion criteria were being severely ill, unable to communicate effectively (e.g. blind, deaf, 
or mute), or speaking in a language other than English when an interpreter was not available. 
10.2.2. Recruitment and ethics 
Eligible people were invited to participate in the study upon registering at the clinic. Written 
consent was obtained from those who were willing to enrol in the study. Two movie vouchers 
were offered as an honorarium to each participant. Patients who opted not to participate in the 
study received the routine service of the clinic. The protocol of the study was approved by the 
Human Research Ethics Committees of both Queensland Health and The University of 
Queensland. This study is registered on the Australian New Zealand Clinical Trials Registry 
(ACTRN12612000315819). 
10.2.3. Randomisation 
Participants were randomly allocated into two groups: face-to-face (FTF) consultation plus 
video consultation (telemedicine group) or two FTF consultations (reference group).  The 
randomisation process also determined the order of consultations for the participants in the 
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telemedicine group: FTF followed by video consultation (FTF-VC) and video consultation 
followed by FTF (VC-FTF). A block randomisation with the block size of eight was used to 
ensure balanced representation of participants in each group. 
10.2.4. Intervention 
All the participants received two consultations by two different endocrinologists during the 
same session of the clinic. Participants in the reference group were seen by the first doctor 
and then the second doctor, both face-to-face. Similarly each participant in the telemedicine 
group received two consultations, but one consultation was via videoconference. The order of 
consultations was randomly allocated to either the first doctor or the second one. The same 
doctor, who was employed specifically for this study, undertook all of the first consultations 
for both groups, but did not provide any recommendation to the patients. The second 
consultation for each participant was carried out by one of the routine doctors of the clinic. 
Assignment of the participants to the doctors for the second consultation was according to the 
clinic routines: normally each patient was assigned to the doctor who consulted the patient in 
the previous appointment. Final recommendations for each patient were made at the end of 
the second consultation. The video consultations for 50% of the individuals in the 
telemedicine group were carried out by the first doctor, and the rest by the second doctor. All 
the doctors participated in this study were endocrinologists with similar qualifications. 
However, their experience with telemedicine was not similar. This is one of the limitations of 
the design of this study. In fact, it was not possible to find endocrinologist with similar 
telemedicine experience to participate in this study. The remote consultations performed by 
doctors who are more experienced with teleconsultation, might be more similar to face-to-
face consultations. 
10.2.5. Equipment and connectivity 
Videoconference, for the telemedicine group, was established between two rooms in the same 
building of the clinic. The telehealth studio of the clinic, where patients sat for tele-
consultation, is equipped with a Tandberg codec 990MXP + camera unit, Sony Bravia 32” 
television, and an Audio-Technica microphone. The camera featured pan, tilt, and zoom 
functions. The endocrinologists used a laptop with 13” screen and Cisco Telepresence Movi 
software ver. 4.2 (Cisco systems, San Jose, California, USA) to connect to the telehealth 
studio. Both Tandberg codec and Cisco Movi are H.264 compliant and capable of high 
definition video (up to 1080p 30 fps) encoding and decoding. The connection was via IP at 
384 kbit/s. This bandwidth is generally regarded as the minimum connection speed for 
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producing an acceptable clinical videoconference. The minimum required bandwidth was 
selected to improve the generalizability of the results of this study to the locations where high 
speed networks are not readily available. 
10.2.6. Outcome measures 
Typical diabetes consultations have several variables, in addition to an interview with the 
patient, which have the potential to be considered as an outcomes measure in a health 
services research. These variables can be categorised as 1) Procedures and findings, and 2) 
Recommendations. Procedures and findings include the components of a consultation the 
help the physician to assess the condition of the patient. For diabetes consultation these 
components are review of home blood glucose readings and lab test results, as well as 
physical examination. Recommendations are the actual outcome of a consultation which 
could be advice to the patient, ordering investigations, changing and/or adjusting the patient's 
drugs, referring the patient to other health care professionals, arranging follow-up visits or 
hospital admission, or a combination of these items. 
Based on the results of two previous studies, requesting laboratory tests and changing 
medications of the patients, followed by referring to other health care providers, were the 
most frequent recommendations made by the endocrinologists for managing diabetes. Of 
these items, changing the medications is the most important recommendation in terms of the 
impact on the management of the diabetes, and can be easily recorded as dichotomised values 
in a single consultation and can then be statistically analysed. Other outcomes of diabetes 
consultations including performance of physical examination, detection of a new sign, and 
general assessment of the patient are not good candidates of the primary outcome measure of 
a research project with limited number of participants because of very high or very low 
frequency of occurrence. 
The outcome measures were changes in prescribing of anti-diabetes, anti-hypertensive and 
lipid lowering drugs. The primary aim of the study was to compare the level of agreement 
between endocrinologists in terms of changes in anti-diabetes drugs in the telemedicine and 
reference groups.  The secondary aim was to compare the levels of agreement between 
endocrinologists for changes in anti-hypertensive and lipid lowering drugs.  
 Four categories of drug were included in the questionnaire: Insulin, other anti-diabetic drugs 
(oral and injectable non-insulin drugs), anti-hypertensive drugs, and lipid lowering drugs. For 
each category four possible types of change were considered: Initiation, Dose adjustment, 
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Change in regimen (type, frequency), and Cessation. If any of these four changes had been 
indicated by the endocrinologist for a drug as the recommendation of the consultation, that 
drug was marked as 'Changed'. For statistical analysis of drug change, Insulin and other anti-
diabetic drugs were consolidated into a group called “anti-diabetic drug”. Similarly, anti-
hypertensive and lipid lowering drugs were also grouped to form “cardiovascular drugs”. The 
status of each group was regarded as 'Changed' if at least one drug in that group had been 
marked as changed, otherwise it was regarded as 'Not changed'. Nevertheless, other important 
aspects of diabetes consultations such as performance of physical examination and detection 
of new signs and diabetes related complications were recorded in this study. 
10.2.7. Data collection and statistical analyses 
A data collection form was developed based on findings of previous studies which analysed 
the process of specialty consultations in the same diabetes outpatient clinic.26, 27. Doctors 
were asked to complete the form for each consultation they provided.  
Basic statistics on patients’ characteristics were presented by number (%), mean (SD) or 
median (IQR). The differences in the distributions of individual characteristics between the 
telemedicine and reference group were tested using appropriate parametric or non-parametric 
statistical tests. The raw agreement between two endocrinologists was presented by 
percentage separately for telemedicine and reference group. The kappa statistics and the areas 
under the receiver operator characteristic (AROC) estimates were obtained along with their 
95% confidence intervals (CI). The interpretation of the level of raw agreements was based 
on Kappa value (≤0.20 poor; 0.21 – 0.40 fair; 0.41 – 0.60 moderate; 0.61 – 0.80 good; and 
0.81 – 0.99 very good; 1.00 perfect agreement).28 For AROC estimation, bootstrapped 
estimates of CI were obtained. 
10.3. Results 
10.3.1. Participants 
A total of 75 participants were recruited from October 2012 to July 2013. Two patients were 
seen by a registrar (specialty trainee) instead of the intended endocrinologists because of 
administrative failure and thus were excluded from the study. Data analysis was performed 
on 146 consultations provided for 73 participants. Based on the randomisation process, 37 
participants were allocated to the reference group, and 36 participants to the telemedicine 
group (Figure  10-1). The mean age of the participants was 57 years (SD=14; range: 24~83) 
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and 34% were female. The two groups were similar on key baseline characteristics 
(Table  10-1). 
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Face-to-face 
Face-to-face 
Figure  10-1 Participant recruitment diagram 
 78 
Table  10-1 Baseline characteristics of the participants by study group (n=73). Variables are summarised 
as count (%) unless otherwise indicated. 
Characteristics Reference group 
n=37 
Telemedicine group 
n=36 
Gender   
Female 14 (38%) 11 (31%) 
Male 23 (62%) 25 (69%) 
   
Age (years)* 59 ± 14 55 ± 14 
   
Distance to the clinic   
<20 km 9 (24%) 15 (42%) 
20-100 km 23 (62%) 16 (44%) 
>100 km 3 (8%) 3 (8%) 
missing data 2 (6%) 2 (6%) 
   
Diabetes Treatment plan   
Diet only 3 (8%) 1 (3%) 
OADd only 3 (8%) 2 (6%) 
Insulin only 19 (51%) 23 (64%) 
Insulin + OADd 9 (24%) 8 (22%) 
Data Missing 3 (8%) 1 (3%) 
   
HbA1c (%)* 8.3 ± 1.4 8.4 ± 1.7 
   
Diabetes complication**   
Retinopathy 13 (35%) 16 (44%) 
Nephropathy 13 (35%) 12 (33%) 
Neuropathy 13 (35%) 12 (33%) 
Ischemic Heart Disease 11 (30%) 8 (22%) 
Foot ulcer 1 (3%) 3 (8%) 
Nil 13 (35%) 9 (25%) 
*Data are means ± SD 
** The precents do not add up to 100 because of cases with both plans 
OAD: Oral Anti-diabetes Drugs 
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10.3.2. Level of agreement between doctors in changing diabetes drugs 
The observed agreement between the endocrinologists for changing anti-diabetes drugs was 
78% (29/37) in the Reference group, and 64% (23/36) in the telemedicine group. Cohen's 
Kappa test showed moderate agreement (0.42, 95% CI: 0.27 – 0.55) in the Reference group 
and fair agreement (0.31, 95% CI: 0.09 – 0.52) in the telemedicine group. However, the 
difference between the two groups was not statistically significant. The area under ROC 
curve for the reference group and the telemedicine group was 0.76 and 0.69 respectively 
(Table  10-2). 
10.3.3. Level of agreement between doctors in changing cardiovascular 
drugs 
The level of observed agreement between the endocrinologists for changing cardiovascular 
drugs was 76% (32/37) in the reference group, and 78% (28/36) in the telemedicine group. 
Cohen's Kappa test showed fair agreement in the reference group (0.27; 95% CI 0.11 – 0.39) 
and the telemedicine group (0.37; 0.15 – 0.75). The levels of agreement between doctors are 
summarised in Table  10-2. 
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Table  10-2 The measures of agreement between the endocrinologists in Reference group vs. telemedicine group 
 Reference group Telemedicine group 
Outcome measures Raw agreement 
% (proportion) 
Kappa (95% CI) AROC (95%CI) Raw agreement 
% (proportion) 
Kappa (95% CI) AROC (95%CI) 
Diabetes drugs 78% (29/37) 0.42** (0.27, 0.55) 0.76* (0.54, 0.92) 64% (23/36) 0.32* (0.09, 0.52) 0.69 (0.52, 0.82) 
Insulin 78% (29/37) 0.50** (0.27, 0.63) 0.82* (0.63, 0.92) 61% (22/36) 0.26 (0.09, 0.29) 0.65 (0.46, 0.83) 
Non-insulin drugs 92% (34/37) 0.37* (0.00, 0.90) 0.96 (0.88, 1.00) 94% (34/36) 0.48** (0.00, 0.63) 0.67 (0.28, 1.00) 
Cardiovascular drugs 76% (28/37) 0.27* (0.11, 0.39) 0.61 (0.48, 0.80) 78% (28/36) 0.37** (0.15, 0.75) 0.66 (0.49, 0.82) 
Anti-hypertension drugs 86% (32/37) 0.38** (-0.04, 0.49) 0.65 (0.48, 0.88) 86% (31/36) 0.46** (0.29, 0.80) 0.72 (0.48, 0.97) 
Lipid lowering drugs 89% (33/37) 0.28* (-0.05, 0.36) 0.61 (0.46, 0.88) 92% (33/36) 0.37** (0.00, 0.72) 0.62 (0.50, 1.00) 
* P ≤ 0.05 
** P ≤ 0.01 
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10.3.4. Impact of the mode of consultation on recommendations made by 
the endocrinologists 
Almost half of the participants (36 out of 73) were in telemedicine group and thus received 
one consultation via videoconference and the other via face-to-face. For these participants, 
the endocrinologists changed anti-diabetes drugs in 61% when consulted FTF, and 47% when 
consulted via videoconference. Changes in cardiovascular drugs were recommended in 31% 
for FTF consultations, and 14% in video consultations. Overall changes recommended for the 
participants in telemedicine group was 72% when consulted FTF, and 58% when consulted 
via videoconference (Table  10-3). 
Table  10-3 Changes in drugs for the participants in the telemedicine group by the mode of consultation 
Outcome measures Face-to-face Videoconference 
Changes in anti-diabetes drugs 22/36 (61%) 17/36 (47%) 
Changes in cardiovascular drugs 11/36 (31%) 5/36 (14%) 
Overall changes in all drugs 26/36 (72%) 21/36 (58%) 
 
10.3.5. Level of agreement between doctors in referring the patients 
The raw agreement between doctors in referring the patients to other health care professionals 
was similar between the two groups (Table  10-4).  
Table  10-4 Referring the patients to other health care professionals by the group of study 
Study group Doctor 2 Total 
Not 
referred 
Back to 
GP 
To another 
specialist 
To allied 
health 
Other 
Reference Doctor 1 Not referred 13 2 2 3 1 21 
Back to GP 0 3 0 1 0 4 
To another specialist 0 1 0 0 0 1 
To allied health 5 0 0 2 0 7 
Other 0 0 0 0 0 0 
Total 18 6 2 6 1 33 
Telemedicine Doctor 1 Not referred 11 0 2 1 0 14 
Back to GP 3 0 1 0 0 4 
To another specialist 2 0 0 0 0 2 
To allied health 4 3 0 4 0 11 
Other 0 0 0 0 0 0 
Total 20 3 3 5 0 31 
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10.4. Discussion 
In this pilot randomised controlled trial we demonstrated that the outcome of consultations 
provided by endocrinologists via videoconferencing is not inferior to those of in-person 
encounters in terms of prescribing medications. The level of agreement in changing anti-
diabetes drugs between endocrinologists in the telemedicine group (64%) was lower than that 
of the reference group (78%), but this difference was not statistically significant. 
Furthermore, this difference was not more than 20%, which was set by a panel of experts as 
the highest clinically accepted inferiority due to the medium of delivery. The between-group 
difference in the level of agreement in changing cardiovascular drugs was also neither 
statistically nor clinically significant.  
The most obvious limiting factor of using telemedicine for clinical consultation of the 
patients is the inability to perform a physical examination. The assessment of a diabetic 
patient, compared with a cardiovascular or respiratory patient, relies more on the results of 
laboratory tests (i.e. blood glucose levels and Haemoglobin A1c) rather than the findings 
from physical examination. However, it is possible in many disciplines to request a GP or a 
nurse practitioner who accompanies the patient at the remote site to perform the required 
physical examination and report the findings back to the specialist (e.g. examination of feet 
for evidence of neuropathy and peripheral vascular disease, and injection sites for 
lipohyperthrophy). Logically, it seems that the more a consultation is dependent on a 
specialised physical examination, the less it will be suitable for telemedicine. 
Any inferiority in the clinical outcome of tele-consultations, either via store-and-forward 
applications such as email or synchronous applications such as videoconferencing, should be 
considered in the context of the condition of the patient and the health care system. In 
Australia, like many other countries, diabetes patients are primarily managed by General 
Practitioners (GP) and the patient is referred to an endocrinologist when there is a need for a 
specialist opinion. In such case, the patient visits an endocrinologist and the process of care is 
returned to the referring GP with the management plan. In this arrangement it can be assured 
that the patient has access to a local GP in case of any potentially dangerous condition due to 
any flaw in remote consultation of the patient. 
Our findings showed that the endocrinologists were more conservative in altering the 
patients' drugs for patients when consulting via videoconference, compared to face-face 
consultation (Table  10-3). This conservative approach might be due to feeling that the patient 
is far away and not readily accessible, as would be a local patient, in case of an adverse effect 
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or unforeseen circumstances. The other possible explanation could be lower confidence of 
doctors on their assessment of the patient's condition when consulting the patient remotely. 
Nevertheless, in this study we just considered one single consultation for each patient. It is 
also noteworthy that the doctors in clinic were not routinely performing video consultation 
and essentially it was a new skill for them and this might have contributed to the conservative 
approach. Doctors with more experience in telemedicine might have had a different approach. 
It is probable that reluctance to change patient medications in one consultation might be 
rectified in the following consultations based on the results of laboratory tests. The design of 
this study did not allow us to test this hypothesis. Nevertheless, there is anecdotal evidence 
that the style of clinical practice varies between doctors of the same qualifications in the same 
discipline; some are more aggressive in changing medications than the others.  
The actual raw agreement for change in cardiovascular drugs was higher than that of diabetes 
drugs. This may suggest that altering cardiovascular drugs, on the basis of a blood pressure 
measurement or lipid profile results, was easier than the diabetes medications.  There might 
have been fewer adjustments of these medications purely because a lot of patients were 
actually to target BP or lipids. The lower agreement in changing diabetes drugs could be 
explained by the need of doctors to take more parameters into account: not only HbA1c but 
also diet, activity, home blood glucose level (BGL) measurements, and compliance that are 
more subjective when one adjusts diabetes drugs.  
There is a trade-off between improved access to health care using ICT–based solutions, and 
the fidelity of the recommendations provided through such encounters. In many situations 
telemedicine provides the patients with access to care that would not otherwise be possible. 
For some other situations, it will be the question of timely access to a lower-quality care 
versus a delayed access to conventional services. Considering the cost and inconvenience of 
long trips to the cities where specialised care is available, several studies have reported that 
the patients would not have attended their specialised care appointment if there was no 
telemedicine application in place. It is also noteworthy that for a proportion of people who 
live in extremely isolated areas, telemedicine is not an alternative to conventional care, but 
the only option. 
This study has several limitations that should be considered for both interpreting the results 
and generalizing to other settings and disciplines. First, the doctors in both groups had equal 
access to the whole patient information, both in electronic and hard copy format. This is not 
the case in the real world except for the settings in which patients' information are stored and 
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retrieved electronically and fully accessible from a distance. Second, the research 
endocrinologist, who conducted the first consultation for all the patients neither managed the 
patient nor was responsible for the consequences of the recommendations that she made for 
the purpose of this research. A more robust design would constitute a situation in which both 
doctors would take the case of any patient equally seriously. We assume this condition 
equally affected both groups, thus had no effect on the ultimate comparison between the 
telemedicine and reference groups. Another limitation of the study is that it does not assess 
the possible importance of face-to-face counselling and motivational interview techniques to 
alter patient's self-management. Nor does the study assess longer term clinical outcomes such 
as HbA1c and we have assumed the change in medications is an important outcome that will 
affect patient outcomes. In an ideal situation, clinical outcomes should be assessed in long 
term (i.e. a RCT comparing a group over 12 months who are managed via face-to-face vs 
telemedicine). 
In this research we studied the intervention in a single consultation for each participant, 
whereas the process of care for the people with diabetes is ongoing and often lifelong. 
Consultation with a specialist often requires several consecutive consultations. It is expected 
that even if the fidelity of care delivered via videoconference is suboptimal in the first 
encounter compared to face-to-face, it will be addressed in the follow-up consultations in the 
light of laboratory test results. Future studies should consider the whole process of care by the 
specialist, comprising several consultations over a longer period of time, similar to what 
patients receive in the real world. 
Appropriately powered clinical trials are needed to confirm the findings of this study on the 
reliability of videoconferencing for specialty remote consultation of diabetes. There is a need 
for developing reliable indicators for assessing the impact of the medium of communication 
on the outcome of office visits to adequately inform the design of health services research, 
especially for evaluating telemedicine interventions. 
10.5. Conclusion 
This study presents the preliminary evidence on the reliability of videoconferencing for 
specialty consultation for people with diabetes. Endocrinologists who provided a consultation 
to the patients remotely using videoconferencing were more conservative in changing the 
anti-diabetes drugs, but not for cardiovascular drugs. Further studies are needed to confirm 
these findings, and assess the clinical outcomes of video consultation in long term. 
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11. CONCLUSIONS AND RECOMMENDATIONS 
11.1. Research purpose 
Access to timely and quality specialised care prevents or delays the development of diabetes 
related complications. However, there are limitations in access to care, especially for people 
living in remote and rural areas. Geographic distance and poor weather as well as social and 
cultural barriers limit access to care for many people worldwide. Telemedicine has the 
potential to address these issues and provide timely access to care for a proportion of 
underserved populations. 
11.2. Study outcomes 
The findings of this thesis shows that telemedicine or similar interventions which are referred 
to as telehealth or ehealth have been researched in almost half of the countries in the world, 
though different countries may use different terms for the same concepts. The number of 
publications in this field of study is rising. This suggests that the field of telemedicine is 
emerging. 
Telemedicine interventions for improving diabetes have used four technologies as the 
medium of communication: telephone, mobile phone, videoconferencing, and online 
solutions. 
The use of videoconferencing for clinical purposes shows a striking increase in 2012 
compared with the previous ten years. If this increase continues, videoconferencing will be 
the main medium of remote consultations in future. This is in parallel with the everyday 
observation of popularity of videoconferencing which is facilitated and readily available by 
smart phones and other portable devices such as tablets. 
The increasing popularity of applications such as Skype, Face Time, and Google Hangout in 
everyday life of people makes videoconferencing more acceptable as a medium of 
communication between health care professionals and patients for health care purposes. 
Smart phones have been used for making videoconferencing for clinical purposes in the past 
few years and the trend of their use seem to be on the rise. 
The process analysis of specialised care in an outpatient diabetes clinic showed that a 
considerable proportion of patients were not physically examined by the endocrinologists. All 
the recommendations could be enacted remotely and in almost all of the cases it was possible 
for a GP to physically examine the patient on behalf of the endocrinologist. For a 
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considerable proportion of the consultations, the endocrinologists reported that it was 
possible to provide the same consultation remotely via videoconferencing if the patient was 
accompanied by a GP. 
The analysis of the process of care delivered via videoconferencing in a tele-endocrinology 
clinic to patients located 210-1800 Km away revealed that the recommendations made by the 
endocrinologists were quite similar to those of the conventional face-to-face clinics. Although 
the endocrinologists believed that it could be possible to make a better decision of the 
consultation was face-to-face, they arranged a face-to-face consultation for less than 6% of 
the patients. For a large proportion of the people with diabetes who are referred to a specialist 
by GP, video consultation can substitute the conventional face-to-face consultation and thus 
eliminate the cost and inconvenience of long distance travel for the patients (and/or their 
carers). 
An instrument for assessing the patient satisfaction with video consultation was developed 
and tested in the tele-endocrinology clinic of a tertiary hospital. Sixteen questions covering 
four dimensions of satisfaction with video consultation were included. The patients who were 
consulted remotely by an endocrinologist via videoconferencing reported the highest 
satisfaction with the 'Communication and rapport' dimension, and with the 'Clinical 
assessment' the lowest. The patients were generally satisfied with the service they received. 
To scientifically assess the reliability of videoconferencing for remote consultation of 
diabetes, there was a need for a rigorously designed research study. Typically a non-
inferiority trial is needed to show that a new treatment or mode of health care delivery is 
within an acceptable range of fidelity to the current solution or the gold standard. Informed 
by the findings of the preliminary studies, a novel non-inferior randomised controlled trial 
was designed to compare the outcome of video consultations with face-to-face consultations. 
To evaluate the impact of the medium of health care delivery (i.e. videoconferencing) on the 
outcome of the consultation, the change in patient's medications was chosen as the outcome 
measure. Since doctors do not always agree with each other on the management of patients, it 
was necessary to establish the level of agreement between endocrinologists when consulting 
patients face-to-face, and use it as a reference. 
The findings of the pilot randomised controlled trial showed that the level of agreement 
between endocrinologists in changing anti-diabetes drugs is lower when one of them consults 
the patient via video, compared with the conventional situation when both endocrinologists 
consult the patient face-to-face. 
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11.3. Implications for the use of videoconferencing 
The need for an assessment of videoconferencing as a medium of clinical care delivery is 
highlighted in the review of the literature (Section one). The findings of this research show 
that video consultation is not inferior to face-to-face consultation for specialty consultation of 
people with diabetes. Specifically, this research has shown that for specialty consultation of 
people with diabetes: 
• The use of videoconferencing has no significant impact on the adjustment of anti-
diabetes drugs 
• The use of videoconferencing has no impact on the adjustment of cardiovascular 
drugs 
• Patient satisfaction with video consultation is generally high for the residents of 
remote and rural areas 
• Overall, videoconferencing is a reliable medium for provision of diabetes specialty 
consultation by an endocrinologist to a patient 
These results are applicable to the settings in which the endocrinologist has access to the 
patient's records and there is a technically reliable videoconferencing system in place to 
connect the endocrinologist to the patient. The results of this research can be generalised to 
the diseases which are managed through a similar model of care. 
11.4. Future research 
Further research is needed to confirm the findings of the pilot trial in this study. Also there is 
a need for the development of a suitable indicator for assessing the immediate outcome of a 
consultation to be used in the future Health Services Research. 
Recent changes in the videoconferencing solutions needs to be monitored and the best 
hardware or software solutions selected for future studies. It looks like the videoconferencing 
solutions are moving from dedicated hardware solutions such as VC codecs to cloud-based 
solutions such as Skype. This transition will have various medico-legal implications that need 
to be addressed. 
There is no standard and validated instrument for evaluating the satisfaction of patients (and 
providers) with video consultation. The instrument which was developed in this research was 
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preliminarily tested, but may need further developments through proper psychometric 
analyses such as Principal Component Analysis or Varimax Rotation.29 
Nevertheless, the health systems in many countries including Australia and the UK are 
already using videoconferencing for clinical purposes, despite the scarcity or lack of evidence 
that supports the reliability of this mode of health care delivery. 
11.5. Policy implications 
The results of this research provide health care managers and health policy makers with the 
preliminary evidence of the reliability of videoconferencing for specialist diabetes 
consultations. Based on the findings of this research, the current model of care for the 
management of diabetes can be redesigned to allow safe integration of videoconferencing as 
a mode of consultation in to the practice of diabetes clinics. Such redesign may consider 
conducting the first visit of a newly referred patient in face-to-face mode, and the following 
visits via videoconferencing for a period of up to one year, or when the patient is discharged 
to the referring GP. This arrangement mimics current attitude of many endocrinologists in 
preforming a comprehensive physical examination at the first visit and then every year, if the 
patient still requires visiting the specialist on a regular basis.  
Although the context of this research was diabetes, the results can be generalised to other 
endocrinology diseases and chronic conditions which have similar models of care. 
Unsurprisingly, the introduction of a new technology such as videoconferencing, tele-
monitoring systems, and web-based solutions may necessitate a redesign in the models of 
health care delivery. Utilising ICT solutions and products, including video consultation, in a 
health care system raises several ethical concerns such as privacy, consent, and confinement 
30. Moreover, shifting towards a technology-centred health care may adversely limit the 
access to care for a group of people on the grounds of poverty and/or digital divide. 
In addition to clinical, technical and ethical issues, several regulatory and managerial issues 
need to be addressed for a successful integration of telemedicine into a health care system. 
Perhaps one of the most important issues is the economic implication of telemedicine. 
Although generally the cost of equipment and connectivity is decreasing, still building up and 
running a telemedicine centre in a hospital or clinic is costly. Apart from the capital 
investment for the physical space, equipment and technical infrastructure, the cost of staff 
training and implementing change in the work place practice is quite considerable. 
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Furthermore, the ongoing cost of running a telemedicine centre such as technical support, 
maintenance, and administration should not be overlooked.  
Achieving equity in access to care is one of the strategic goals for many health care systems. 
Telemedicine can play an important role in achieving this goal. It has the potential to bridge 
the geographical gap for the residents of remote and rural areas. Telemedicine can also 
overcome the barriers such as restricted mobility and frailty that may limit the access to care 
for urban populations. Other people who may benefit from telemedicine are the patient who 
are culturally isolated or the people with diseases that are associated with stigma such as 
psychiatric disorders or HIV/AIDS.31 
The Australian Government Department of Health and Ageing (DoHA) established the 
reimbursement of the service for video consultations in remote, regional and out metropolitan 
areas in 2011.32 Similar financial supports have been provided, though very limited, in other 
countries such as the USA, but it is still a major issue to be addressed by many nations 
around the world. 
People living in cities can also benefit from video consultation. The observation of the 
routine work flow of a diabetes clinic in Brisbane with more than two million population 
revealed that it takes about four to five hours for a patient to attend a 20-minutes appointment 
with an endocrinologist. This usually costs the patient one day off work if he/she is working. 
The time required for a round trip to the clinic and waiting for the appointment can easily be 
saved in case of video consultation. In addition to the travel cost, there are also other costs 
such as cost of child care or parking fee associated with having an in-person consultation for 
many patients. Nevertheless, a proportion of patients, especially those with disabling 
complications or frailty, have more limitation in access to care because they need to be 
accompanied by a family member, friend, or carer. Telemedicine can play an important role 
in eliminating this limitation, too. 
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11.6. Conclusions 
The findings of this research demonstrated that videoconferencing is a reliable means of 
communication between endocrinologists and patients. Video consultation can substitute a 
considerable proportion of conventional outpatient specialty consultations for people with 
diabetes. Known limitations of videoconferencing for clinical purposes did not have 
remarkable impact on the outcome of consultation in terms of adjustment of patient's 
medications. The results of this research should be confirmed by further studies with 
appropriate power. 
In addition to conventional clinical knowledge, the doctors who are going to use telemedicine 
as a routine part of their practice may need additional skills such as communication and 
fostering relationship with the patient at a distance. Moreover, access to the latest patient's 
information and coordination of remote consultation sessions are pre-requisite to the 
proposed telemedicine application. 
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